{"gene":"SH2B1","run_date":"2026-04-28T20:42:07","timeline":{"discoveries":[{"year":2005,"finding":"SH2B1 (SH2-B) is an endogenous enhancer of leptin sensitivity that binds JAK2 and promotes leptin-stimulated activation of hypothalamic JAK2, phosphorylation of STAT3 and IRS2; SH2B1 null mice show severely impaired leptin signaling and develop obesity, hyperglycemia, and metabolic syndrome.","method":"Genetic knockout mouse model; leptin signaling assays (JAK2 activation, STAT3/IRS2 phosphorylation); cultured cell overexpression with PTP1B inhibition assay","journal":"Cell metabolism","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined cellular and metabolic phenotypes, replicated across multiple signaling readouts, foundational paper with 186 citations","pmids":["16098827"],"is_preprint":false},{"year":2004,"finding":"SH2B1 promotes activation of the PI3-kinase pathway in response to leptin by directly binding IRS1 and IRS2 (via its PH and SH2 domains) and mediating formation of a JAK2/SH2B1/IRS1 or IRS2 ternary complex, thereby enhancing leptin-stimulated tyrosine phosphorylation of IRS1/IRS2 and subsequent PI3K/Akt activation.","method":"In vitro binding assays (GST pulldown), co-immunoprecipitation in HEK293 cells stably expressing LRb, mutagenesis of SH2B1 binding domains, MEF KO reconstitution","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro pulldown plus co-IP in intact cells plus mutagenesis plus KO rescue, multiple orthogonal methods","pmids":["15316008"],"is_preprint":false},{"year":2004,"finding":"SH2B1 (SH2-B) directly enhances insulin receptor autophosphorylation and tyrosine phosphorylation of IRS1/IRS2 in an SH2 domain-dependent manner; systemic deletion of SH2-B impairs insulin receptor signaling in liver, muscle, and fat and causes age-dependent hyperinsulinemia, hyperglycemia, and glucose intolerance.","method":"Genetic KO mouse; in vitro kinase assays; cultured cell overexpression and KO analysis of IR, IRS1/IRS2 phosphorylation, Akt and ERK1/2 activation","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro kinase assay combined with KO mouse and cell signaling assays, replicated by multiple groups","pmids":["15314154"],"is_preprint":false},{"year":2004,"finding":"Tyrosine 813 is a site of JAK2 autophosphorylation (identified by 2D phosphopeptide mapping and phospho-specific antibody) that is required for SH2B1β to bind JAK2 and to enhance JAK2 activity and STAT5B phosphorylation; the homologous Tyr785 in JAK3 is similarly autophosphorylated and required for SH2B1β binding.","method":"2D phosphopeptide mapping, phosphospecific antibody, mutagenesis (Y813F), co-immunoprecipitation, kinase activity assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 — phosphopeptide mapping plus phospho-specific antibody plus mutagenesis in intact cells; single rigorous paper","pmids":["15121872"],"is_preprint":false},{"year":2007,"finding":"SH2B1 regulates leptin/JAK2 signaling by dual mechanisms: (1) constitutive binding via non-SH2 domain to non-phosphorylated JAK2 inhibits basal JAK2; (2) leptin-stimulated JAK2 phosphorylation at Tyr813 recruits the SH2 domain of SH2B1 to activate JAK2; additionally, SH2B1 interacts with IRS1 to facilitate IRS1 phosphorylation independent of JAK2 Tyr813.","method":"Co-immunoprecipitation, JAK2 Y813F mutagenesis, leptin stimulation assays, IRS1 phosphorylation assays in cultured cells","journal":"Molecular endocrinology","confidence":"High","confidence_rationale":"Tier 2 — multiple co-IP experiments with mutagenesis defining two distinct binding modes; single lab but multiple orthogonal approaches","pmids":["17565041"],"is_preprint":false},{"year":2007,"finding":"Neuronal SH2B1β specifically expressed in neural tissue is sufficient to correct metabolic disorders (obesity, leptin resistance, insulin resistance, glucose intolerance) in SH2B1 knockout mice and improves hypothalamic JAK2-mediated leptin signaling, demonstrating that neuronal SH2B1 is the primary site of metabolic action.","method":"Neuron-specific SH2B1 transgenic rescue crossed onto KO background (TgKO mice); hypothalamic leptin signaling assays; metabolic phenotyping","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 — tissue-specific genetic rescue with defined molecular and phenotypic readouts; 163 citations","pmids":["17235396"],"is_preprint":false},{"year":2009,"finding":"Peripheral SH2B1 directly stimulates insulin receptor catalytic activity (demonstrated by in vitro kinase assay with purified SH2B1) and inhibits tyrosine dephosphorylation of IRS-1/IRS-2 by binding to them; the SH2 domain alone is both required and sufficient for insulin receptor activation.","method":"In vitro insulin receptor kinase assay with purified SH2B1; in vitro IRS dephosphorylation assay; TgKO mice expressing SH2B1 only in brain; co-immunoprecipitation","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstituted kinase assay plus in vitro dephosphorylation assay plus domain mutagenesis plus genetic mouse model","pmids":["19542202"],"is_preprint":false},{"year":2001,"finding":"SH2B1 (SH2-B) and APS exist as homopentamers and/or heteropentamers mediated by their N-terminal dimerization domain; SH2-B multimerization is required for enhancing TrkA autophosphorylation magnitude and duration in response to NGF and for TrkA/SH2-B-mediated morphological differentiation of PC12 cells.","method":"Biochemical structure-function analysis; co-immunoprecipitation; dominant-negative overexpression; PC12 cell NGF differentiation assays","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 — structure-function plus cellular assays in single lab; 70 citations","pmids":["11238898"],"is_preprint":false},{"year":1999,"finding":"SH2B1β (SH2-Bbeta) is required for NGF-induced neuronal differentiation: it binds to activated TrkA via its SH2 domain, is tyrosyl-phosphorylated in response to NGF, and overexpression of a dominant-negative SH2 domain mutant (R555E) blocks NGF-induced neurite outgrowth in PC12 cells without altering TrkA, Shc, PLCγ phosphorylation or ERK1/2 activation, indicating a novel downstream pathway.","method":"GST-fusion pulldown, co-immunoprecipitation, overexpression of wild-type and SH2 domain mutant in PC12 cells, neurite outgrowth assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — in vitro binding plus co-IP plus dominant-negative mutagenesis with clear cellular phenotype; 78 citations","pmids":["10187854"],"is_preprint":false},{"year":1999,"finding":"SH2B1 (SH2-Bgamma isoform) interacts specifically with the insulin receptor kinase domain, requiring phosphorylation of Y1146 in the activation loop triple-tyrosine motif, making it one of only two signaling molecules shown to interact directly with this residue.","method":"In vitro binding assays with insulin receptor kinase domain, mutagenesis of IR Y1146","journal":"Mammalian genome","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro binding with mutagenesis; single lab","pmids":["10594240"],"is_preprint":false},{"year":2000,"finding":"SH2B1β (SH2-Bbeta) is required for growth hormone-induced actin reorganization (membrane ruffling and pinocytosis); it co-localizes with filamentous actin in GH-induced membrane ruffles; both SH2 domain-defective and truncation mutants lacking the N-terminus inhibit GH-induced ruffling, acting via a mechanism distinct from JAK2 kinase stimulation.","method":"Cell fractionation, confocal microscopy, overexpression of wild-type and mutant SH2B1 in 3T3-F442A cells, membrane ruffling and pinocytosis assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — localization plus functional assays with mutagenesis; distinct mechanism established","pmids":["10777618"],"is_preprint":false},{"year":2001,"finding":"SH2B1β specifically activates JAK2 (but not JAK1 or JAK3) when overexpressed, while APS negatively regulates JAK2 and JAK1 but not JAK3; both bind and are phosphorylated by JAK kinases, demonstrating isoform- and kinase-specificity of SH2B family regulation.","method":"Overexpression in cells, co-immunoprecipitation, kinase activity/phosphorylation assays for JAK1, JAK2, JAK3, STAT5B","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — reciprocal binding and kinase activity assays across multiple JAK family members; single lab","pmids":["11751854"],"is_preprint":false},{"year":2002,"finding":"SH2B1β binds to FGFR3 via the SH2 domain at FGFR3 phosphotyrosines Tyr-724 and Tyr-760; SH2B1β is tyrosyl-phosphorylated by activated FGFR3 mutants and enhances FGFR3-stimulated STAT5 phosphorylation and nuclear translocation.","method":"Yeast two-hybrid screen, co-immunoprecipitation, FGFR3 mutagenesis (Y724, Y760), STAT5 nuclear translocation assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — yeast two-hybrid confirmed by co-IP plus mutagenesis plus functional STAT5 assay","pmids":["11827956"],"is_preprint":false},{"year":2004,"finding":"SH2B1β undergoes constitutive nucleocytoplasmic shuttling; a nuclear export sequence (amino acids 224–233) containing two critical lysines is required for cytoplasmic/membrane localization and for SH2B1β to enhance NGF-induced neurite outgrowth; nuclear-export-defective mutants cannot support differentiation despite normal ERK activation.","method":"Leptomycin B treatment, NES deletion/mutation, confocal microscopy in PC12 and COS-7 cells, stable overexpression neurite outgrowth assay","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 — localization directly tied to functional consequence via NES mutagenesis; single lab","pmids":["15082760"],"is_preprint":false},{"year":1999,"finding":"NGF stimulates phosphorylation of SH2B1 (SH2-B) on multiple serines/threonines via kinases downstream of MEK (ERKs 1 and 2 phosphorylate SH2Bbeta on Ser-96 in vitro); however, the S96A mutant still supports NGF-induced neurite outgrowth, suggesting additional MEK-downstream sites are involved.","method":"In vitro ERK kinase assay, MEK inhibitor PD98059, protein phosphatase 2A treatment, mutagenesis (S96A), NGF-induced differentiation assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1-2 — in vitro kinase assay plus pharmacological inhibitor plus mutagenesis; single lab","pmids":["10473609"],"is_preprint":false},{"year":2005,"finding":"SH2B1 homodimerizes (and forms heterodimers with APS) via a unique N-terminal domain; dimerization brings two SH2 domains to bind two JAK2 pTyr813 sites, creating heterotetrameric JAK2-(SH2B1)2-JAK2 complexes that transactivate JAK2 at low adapter concentrations, but inhibit kinase activity at high concentrations.","method":"Yeast two-hybrid, cellular transfection co-immunoprecipitation, kinase activity assays at varying SH2B1/APS concentrations","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 — yeast two-hybrid confirmed by co-IP plus concentration-dependent kinase assays; mechanistic model supported","pmids":["15767667"],"is_preprint":false},{"year":2006,"finding":"SH2B1 (and APS) bind JAK2 at multiple sites; binding at pTyr813 is essential for SH2B1-mediated JAK2 activation; a phosphoTyr813-independent binding site mediates inhibition; the region 809–811 in JAK2, likely within JH1/JH2 domains, is a critical component of the regulatory region that SH2B1 binding stabilizes into an active conformation.","method":"JAK2 truncation and point mutagenesis, in vitro kinase assays, binding assays for multiple JAK2 sites","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 — systematic mutagenesis across JAK2 combined with binding and kinase assays; single lab","pmids":["16914724"],"is_preprint":false},{"year":2006,"finding":"Crystal structure (2.35 Å) of the SH2B1 SH2 domain in complex with the JAK2 pTyr813 phosphopeptide reveals canonical SH2-phosphopeptide binding with specific recognition of glutamate at +1 and hydrophobic at +3 positions; the SH2B1 SH2 domain prefers JAK2 over insulin receptor due to its monomeric state (versus dimeric APS SH2).","method":"X-ray crystallography (2.35 Å), biochemical binding assays comparing SH2B1 vs APS SH2 domains","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 — high-resolution crystal structure with biochemical validation of specificity determinants","pmids":["16824542"],"is_preprint":false},{"year":2003,"finding":"SH2B1β is a positive regulator of NGF-mediated Akt/PKB activation in PC12 cells; it enhances and prolongs NGF-induced phosphorylation of Akt on Ser473, leading to increased phosphorylation of GSK-3 and FOXO forkhead transcription factors and their cytoplasmic retention; a dominant-negative SH2 domain mutant blocks these effects.","method":"Stable overexpression of SH2Bbeta and R555E mutant in PC12 cells, Akt kinase assays, phospho-Akt/GSK-3/FOXO western blotting, immunolocalization of FKHR","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — kinase assay plus immunolocalization plus mutagenesis; single lab, multiple endpoints","pmids":["14565960"],"is_preprint":false},{"year":2007,"finding":"SH2B2β, a novel isoform of SH2B2 lacking an SH2 domain, acts as an endogenous inhibitor of SH2B1: it binds SH2B1 via the dimerization/PH domain and markedly attenuates SH2B1-promoted JAK2 activation, IRS-1 phosphorylation by JAK2, and insulin-stimulated IRS-1 phosphorylation.","method":"GST-fusion pulldown in vitro, co-immunoprecipitation in intact cells, JAK2 kinase assays, insulin signaling assays","journal":"Endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro pulldown confirmed by co-IP, combined with functional kinase and signaling assays","pmids":["17204555"],"is_preprint":false},{"year":2007,"finding":"SH2B1 (SH2-B) promotes adipocyte differentiation by enhancing insulin/IGF-I receptor signaling through Akt, leading to phosphorylation and nuclear exclusion of Foxo1, thereby increasing PPARγ mRNA levels; PPARγ up-regulation by SH2B1 is blocked by PI3K inhibitors but not MEK inhibitors.","method":"Retroviral overexpression and KO MEF differentiation assays, PPARγ mRNA quantification, Akt/Foxo1 phosphorylation assays, PI3K and MEK inhibitor treatments","journal":"Molecular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 — KO and overexpression with pharmacological pathway dissection; single lab","pmids":["17312274"],"is_preprint":false},{"year":2010,"finding":"Neuronal SH2B1 regulates energy balance by controlling a leptin receptor neuron/sympathetic nervous system (SNS)/brown adipose tissue/thermogenesis axis; LepR neuron-specific deletion of Sh2b1 abrogates leptin-stimulated sympathetic nerve activation and impairs BAT thermogenic programs, causing cold intolerance and progressive degeneration of adipose SNS.","method":"LepR neuron-specific conditional KO, adult-onset hypothalamic-specific AAV-ablation, hypothalamic overexpression; sympathetic nerve recording; BAT thermogenesis measurement; metabolic phenotyping","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — cell-type-specific KO plus overexpression rescue with defined physiological readouts including direct nerve recording","pmids":["32251290"],"is_preprint":false},{"year":2010,"finding":"The SH2 domain of neuronal SH2B1 is required for maintaining normal body weight and glucose metabolism in vivo; SH2 domain-defective mutant (R555E) expressed neuron-specifically in WT mice promotes obesity and insulin resistance in a dominant-negative manner, while the SH2 domain alone (DeltaN503) is insufficient to rescue the KO phenotype, demonstrating N-terminal regions are also required.","method":"Three lines of neuron-specific transgenic mice (WT, R555E, DeltaN503) crossed with SH2B1 KO; metabolic phenotyping; glucose/insulin tolerance tests","journal":"Endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo mutagenesis rescue experiment with three distinct constructs; single lab","pmids":["20484460"],"is_preprint":false},{"year":2012,"finding":"SH2B1 associates with the erythropoietin receptor (EPO-R) via its SH2 domain at phosphotyrosines 343 and 401 (pYXXL sequence); SH2B1β preferentially associates with EPO-R over JAK2 in hematopoietic cells; constitutive SH2B1 association with EPO-R is necessary for optimal SH2-dependent recruitment; absence of SH2B1 leads to enhanced EPO-R downstream signaling, indicating SH2B1 is a negative regulator of EPO signaling.","method":"COLT screening, co-immunoprecipitation, in vitro mixing assays, SH2 domain mutagenesis, EPO stimulation signaling assays in cells lacking SH2B1","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — COLT binding assay plus reciprocal co-IP plus in vitro mixing plus loss-of-function signaling; single lab","pmids":["22669948"],"is_preprint":false},{"year":2013,"finding":"SH2B1 in pancreatic β-cells promotes β-cell survival and proliferation by enhancing insulin- and IGF-1-stimulated PI3K/Akt activation; pancreas-specific KO mice show increased β-cell apoptosis, decreased proliferation, reduced β-cell mass, and exacerbated glucose intolerance on high-fat diet.","method":"Pancreas-specific conditional KO mice; high-fat diet metabolic phenotyping; STZ challenge; β-cell mass histomorphometry; PI3K/Akt signaling assays in INS-1 cells and islets","journal":"Diabetes","confidence":"Medium","confidence_rationale":"Tier 2 — tissue-specific KO with defined molecular (PI3K/Akt) and cellular phenotype readouts; single lab","pmids":["24150605"],"is_preprint":false},{"year":2013,"finding":"SH2B1 promotes insulin expression in β-cells by enhancing JAK2 activation of the insulin promoter and increasing Pdx1 expression and Pdx1 recruitment to the insulin promoter; SH2B1 knockdown reduces, and overexpression increases, insulin expression and glucose-stimulated insulin secretion.","method":"siRNA knockdown and overexpression in INS-1 832/13 cells; insulin promoter-luciferase assay; chromatin immunoprecipitation (ChIP) for Pdx1; SH2B1-deficient islet analysis","journal":"Molecular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP assay plus promoter reporter plus KD/OE with multiple molecular readouts; single lab","pmids":["24645678"],"is_preprint":false},{"year":2015,"finding":"SH2B1 mediates pathological cardiac hypertrophy by activating the JAK2/STAT3 signaling cascade; cardiac-specific SH2B1 overexpression exacerbates pressure overload-induced hypertrophy, whereas SH2B1 deletion is protective; pharmacological JAK2 inactivation rescues hypertrophic abnormalities in SH2B1-overexpressing transgenic mice.","method":"Cardiac-specific SH2B1 transgenic mice and global KO rat model; aortic banding model; echocardiography; JAK2/STAT3 pathway assays; JAK2 inhibitor rescue experiments","journal":"Cardiovascular research","confidence":"Medium","confidence_rationale":"Tier 2 — gain-of-function and loss-of-function mouse/rat models with pharmacological pathway rescue; single lab","pmids":["26077624"],"is_preprint":false},{"year":2015,"finding":"SH2B1β interacts with IRSp53 via its N-terminal proline-rich domains; SH2B1-IRSp53 complexes co-localize at the plasma membrane and together promote filopodium formation, neurite initiation, and dendritic branching in hippocampal and cortical neurons.","method":"Co-immunoprecipitation in vivo and in vitro, confocal co-localization, Triton X-100 fractionation, overexpression of SH2B1β and IRSp53 in neurons, neurite/filopodia counting","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — reciprocal co-IP plus co-localization plus functional neuronal morphology assays; single lab","pmids":["25586189"],"is_preprint":false},{"year":2013,"finding":"SH2B1 promotes BDNF-induced neurite outgrowth by enhancing MEK-ERK1/2 and PI3K-AKT signaling pathways downstream of TrkB; SH2B1β also enhances BDNF-stimulated STAT3 phosphorylation on Ser727; the SH2 domain and tyrosine phosphorylation of SH2B1β are required for these effects.","method":"Overexpression of SH2B1β and mutants in PC12-TrkB and hippocampal cells; pathway inhibitors (MEK, PI3K); neurite outgrowth assays; western blotting of p-ERK, p-AKT, p-STAT3","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological pathway dissection plus mutagenesis plus cellular morphology assays; single lab","pmids":["24260264"],"is_preprint":false},{"year":2018,"finding":"SH2B1β is phosphorylated by TrkA at Tyr753 in the unique α-tail (and at Tyr439 and Tyr55 shared by α and β isoforms); phosphorylation of Tyr753 in SH2B1α inhibits nucleocytoplasmic cycling and prevents SH2B1α from enhancing NGF-mediated neurite outgrowth, TrkA autophosphorylation, Akt/PLCγ phosphorylation, and gene expression; Y753F mutation restores these functions.","method":"Mutagenesis (Y753F and others), co-expression with TrkA, neurite outgrowth assays, western blotting for p-Akt and p-PLCγ, nuclear cycling assays","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 — mutagenesis-based identification of phosphosite with multiple downstream functional readouts; single lab","pmids":["29229648"],"is_preprint":false},{"year":2016,"finding":"SH2B1 interacts with histone H1 and is required for removal of histone H1 from active transcription sites; SH2B1 promotes histone H3K4me3 induction and H3K9me3 reduction at IGF2 and MYOG promoters/enhancers, is required for MyoD occupancy at these loci, and promotes myogenesis; knockdown delays chromatin condensation and decreases myotube formation.","method":"ChIP for histone marks and MyoD occupancy, co-immunoprecipitation with histone H1, SH2B1 knockdown, myotube formation assays","journal":"Biochimica et biophysica acta. Gene regulatory mechanisms","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP with multiple histone marks plus co-IP plus loss-of-function phenotype; single lab","pmids":["28039048"],"is_preprint":false},{"year":2022,"finding":"SH2B1 promotes myelination in peripheral nervous system Schwann cells by maintaining phosphorylation of cytohesin-2 at Tyr381, which is required for Arf6 activity and normal myelin thickness; Schwann cell-specific loss of SH2B1 reduces cytohesin-2 phosphorylation and myelin thickness; SH2B1 and the phosphatase PTP4A1 act antagonistically to control this phosphorylation.","method":"Schwann cell-specific knockdown in mice (in vivo), HEK293T co-expression experiments, Y381F cytohesin-2 knockin mice, Arf6 activity assays, myelin thickness measurements","journal":"Science signaling","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo Schwann cell-specific KD plus knockin mouse plus biochemical Arf6 activity assays; single lab","pmids":["35077201"],"is_preprint":false},{"year":2022,"finding":"SH2B1 neuronal protection against MPTP-induced dopaminergic neurodegeneration is mediated by binding to HSC70, which promotes HSC70-dependent recognition and lysosomal translocation/degradation of PLIN4, thereby suppressing lipid peroxidation stress; Sh2b1 deficiency exacerbates PD-like pathology and AAV-HSC70 rescue is effective only in WT but not Sh2b1-deficient mice.","method":"MPTP mouse PD model, Sh2b1 KO and neuron-specific overexpression, co-IP of SH2B1-HSC70, PLIN4 degradation assays, AAV-HSC70 rescue, lipid peroxidation measurement","journal":"Redox biology","confidence":"Medium","confidence_rationale":"Tier 2 — co-IP defining complex plus in vivo rescue epistasis; single lab, multiple orthogonal methods","pmids":["35390677"],"is_preprint":false},{"year":2022,"finding":"The brain-specific SH2B1δ isoform localizes primarily to nucleoli (driven by two unique highly basic regions) and to the plasma membrane; its nucleolar localization is required for SH2B1δ to maximally enhance neurite complexity and BDNF-induced expression of Egr1, Arc, and FosL1 in hippocampal neurons.","method":"Isoform-specific overexpression in Sh2b1 KO hippocampal neurons, confocal microscopy, mutagenesis of nucleolar targeting regions, neurite morphology analysis, BDNF-induced gene expression assays","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 — localization tied to functional consequence via domain mutagenesis; single lab","pmids":["35019135"],"is_preprint":false},{"year":2016,"finding":"4E-BP2 deletion induces translation of SH2B1, which then forms a complex with IRS2 and JAK2 that prevents IRS2 ubiquitination; this SH2B1-dependent stabilization of IRS2 increases Akt signaling, reduces p27, and promotes β-cell proliferation and survival, linking mTORC1 signaling to IRS2 stability through SH2B1.","method":"4E-BP2 KO mice, co-immunoprecipitation (SH2B1/IRS2/JAK2 complex), IRS2 ubiquitination assay, Akt/p27 signaling assays, cytokine treatment survival assays","journal":"Diabetes","confidence":"Medium","confidence_rationale":"Tier 2 — co-IP defining ternary complex plus ubiquitination assay plus KO mouse; single lab","pmids":["27217487"],"is_preprint":false},{"year":2019,"finding":"The PH domain of SH2B1 is critical for energy balance and glucose homeostasis; mice homozygous for a human obesity-associated P322S PH domain variant show substantial prenatal lethality; mice with a two-amino acid deletion in the PH domain (ΔPR) develop obesity and insulin resistance beyond that attributable to adiposity alone.","method":"PH domain variant knockin mouse models (P322S and ΔPR); metabolic phenotyping; glucose and insulin tolerance testing","journal":"Diabetes","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo PH domain mutagenesis in mice with defined metabolic phenotyping; single lab","pmids":["31439647"],"is_preprint":false},{"year":2017,"finding":"The SH2 domain of SH2B1 binds diverse phosphotyrosine-containing peptides (JAK2 pY813, insulin receptor activation loop, IRS-1/2) with distinct thermodynamic signatures; residues K575 and R578 play distinct roles in different binding modes; crystal structure reveals conformationally plastic loops enabling recognition of chemically disparate +3 position residues.","method":"Binding assays (ITC/fluorescence), X-ray crystallography of SH2B1 SH2 domain, alanine scanning mutagenesis of binding residues","journal":"Proteins","confidence":"Medium","confidence_rationale":"Tier 1 — structural plus biochemical binding with mutagenesis; single lab","pmids":["29127727"],"is_preprint":false},{"year":2023,"finding":"Hippocampal SH2B1 in inhibitory (but not excitatory) neurons controls fluid intelligence-related cognitive functions (working memory, short-term recognition memory, behavioral flexibility) by restraining ERK signaling; selective ablation of Sh2b1 in hippocampal inhibitory neurons causes aberrantly enhanced ERK signaling, and pharmacological ERK inhibition reverses associated behavioral impairments.","method":"Cell-type-specific conditional KO in mouse hippocampus (inhibitory vs excitatory neurons), behavioral cognitive testing, single-cell transcriptomic profiling, pharmacological ERK inhibitor rescue","journal":"Research (Washington, D.C.)","confidence":"Medium","confidence_rationale":"Tier 2 — cell-type-specific KO with pathway-specific pharmacological rescue; single lab","pmids":["38434247"],"is_preprint":false},{"year":2008,"finding":"PSM/SH2B1 splice variants (with activity order γ > δ > α > β) enhance Src kinase catalytic activity by increasing V(max) and decreasing K(m) for ATP; SH2B1 variants and Src are found in the same immune complex; SH2B1 also enhances Src-mediated STAT3 activation; dominant-negative PH or SH2 domain peptides inhibit Src activity.","method":"Co-immunoprecipitation, in vitro Src kinase assays (V(max)/K(m) measurement), Src inhibitor herbimycin A, dominant-negative peptide mimetics, STAT3 reporter assays","journal":"Journal of cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro kinase assay with Km/Vmax parameters plus co-IP plus dominant-negative; single lab","pmids":["18247337"],"is_preprint":false},{"year":2018,"finding":"Neural deletion of Sh2b1 decreases brain weight and increases reactive aggression; brain-specific KO mice show increased c-fos immunoreactivity in amygdala and periaqueductal gray (core aggression circuits); brain-specific restoration of Sh2b1 normalizes brain size and reverses pathological aggression; at the molecular level, Sh2b1 enhances neurotrophin-stimulated neuronal differentiation and protects against oxidative stress-induced neuronal death.","method":"Global and brain-specific conditional KO; resident-intruder aggression paradigm; c-fos immunoreactivity mapping; brain-specific AAV restoration; neurotrophin signaling and oxidative stress protection assays","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 — brain-specific KO and rescue with defined circuit-level and molecular readouts; single lab","pmids":["29180441"],"is_preprint":false},{"year":2020,"finding":"SH2B1 protects cardiomyocytes from ischemia/reperfusion injury via activation of the PI3K/AKT pathway; adenovirus-mediated SH2B1 overexpression reduces I/R-induced apoptosis, ROS, and inflammation; pharmacological PI3K/AKT inhibition (LY294002) abolishes SH2B1's protective effects.","method":"In vivo I/R model (LAD ligation) and in vitro H/R model in cardiomyocytes; adenoviral SH2B1 overexpression; PI3K inhibitor LY294002; apoptosis, ROS, and inflammation assays","journal":"International immunopharmacology","confidence":"Low","confidence_rationale":"Tier 3 — gain-of-function with pharmacological rescue but no KO or binding confirmation; single lab","pmids":["32222636"],"is_preprint":false}],"current_model":"SH2B1 is a cytoplasmic adaptor protein that acts as a positive regulator of multiple receptor tyrosine kinase and JAK-associated cytokine receptor signaling pathways: it binds constitutively (via non-SH2 regions) and upon leptin/GH stimulation (via its SH2 domain to JAK2 pTyr813) to JAK2, enhancing JAK2 catalytic activity and stabilizing an active conformation; it also directly stimulates insulin receptor autophosphorylation and assembles ternary complexes (JAK2/SH2B1/IRS1 or IRS2) that promote IRS1/2 phosphorylation while protecting IRS proteins from dephosphorylation, thereby amplifying PI3K/Akt signaling; neuronal SH2B1 additionally controls leptin receptor neuron–SNS–BAT thermogenesis, brain development, aggression circuits, and neurotrophic factor (NGF, BDNF) signaling by regulating TrkA/TrkB-mediated ERK, Akt, and actin-reorganization pathways, with isoform-specific functions determined by distinct C-terminal tails and subcellular localizations (cytoplasm/plasma membrane for β; nucleolus for δ)."},"narrative":{"teleology":[{"year":1999,"claim":"Establishing SH2B1 as a TrkA-binding adaptor required for NGF-induced neuronal differentiation answered whether this SH2 protein had neurotrophic signaling functions beyond its known role in cytokine receptor pathways.","evidence":"GST pulldown, co-IP, and dominant-negative SH2 mutant (R555E) blocking neurite outgrowth in PC12 cells","pmids":["10187854"],"confidence":"High","gaps":["The downstream pathway mediating neurite outgrowth was distinct from ERK and remained unidentified","Whether SH2B1 acts on TrkA autophosphorylation magnitude was not tested"]},{"year":1999,"claim":"Demonstrating direct SH2B1γ interaction with the insulin receptor activation loop at pY1146 established SH2B1 as one of the first adaptor proteins binding this specific autophosphorylation site.","evidence":"In vitro binding assays with IR kinase domain mutagenesis","pmids":["10594240"],"confidence":"Medium","gaps":["Functional consequence of this binding on IR kinase activity was not measured","Only in vitro binding without cellular validation"]},{"year":2000,"claim":"Linking SH2B1β to GH-induced actin reorganization (membrane ruffling) revealed a cytoskeletal effector function distinct from its JAK2 kinase-stimulatory role.","evidence":"Confocal co-localization with F-actin, mutagenesis of SH2 and N-terminal domains, ruffling/pinocytosis assays in 3T3-F442A cells","pmids":["10777618"],"confidence":"Medium","gaps":["The actin-regulatory intermediates (Rho GTPases, WASP) were not identified","In vivo relevance was not tested"]},{"year":2001,"claim":"Discovering that SH2B1 forms homopentamers/heteropentamers with APS via its N-terminal domain, and that multimerization is required for TrkA activation, established oligomerization as a core mechanistic feature.","evidence":"Biochemical structure-function analysis, co-IP, dominant-negative overexpression, PC12 NGF differentiation","pmids":["11238898"],"confidence":"Medium","gaps":["Stoichiometry later revised to dimers; pentameric model not independently confirmed","Structural basis of multimerization was unresolved"]},{"year":2004,"claim":"Identifying JAK2 pTyr813 as the SH2B1 SH2-domain docking site, and showing it is required for SH2B1-mediated JAK2 activation, defined the key phosphoswitch controlling the SH2B1–JAK2 regulatory interaction.","evidence":"2D phosphopeptide mapping, phospho-specific antibody, Y813F mutagenesis, co-IP, kinase assays","pmids":["15121872"],"confidence":"High","gaps":["How SH2B1 binding at pY813 mechanistically activates the JAK2 kinase domain was not structurally resolved","Role of a second, phosphotyrosine-independent binding site was only later characterized"]},{"year":2004,"claim":"Demonstrating that SH2B1 assembles a JAK2/SH2B1/IRS1-2 ternary complex via PH and SH2 domains to amplify leptin-stimulated PI3K/Akt signaling established its scaffold function beyond simple kinase activation.","evidence":"GST pulldown, co-IP in LRb-expressing HEK293, mutagenesis, MEF KO reconstitution","pmids":["15316008"],"confidence":"High","gaps":["Relative contribution of scaffold vs. kinase-enhancer function was not separated in vivo"]},{"year":2004,"claim":"Showing that SH2B1 directly stimulates insulin receptor autophosphorylation and that global KO causes diabetes-like metabolic syndrome established SH2B1 as a bona fide insulin signaling amplifier with physiological consequence.","evidence":"In vitro IR kinase assays, KO mouse metabolic phenotyping, IRS1/2 and Akt phosphorylation assays","pmids":["15314154"],"confidence":"High","gaps":["Whether the IR-activating and JAK2-activating functions are mechanistically identical was unresolved"]},{"year":2005,"claim":"Resolving the oligomeric state to dimers and showing that SH2B1 dimers bridge two JAK2 molecules into a transactivating heterotetramer provided a concentration-dependent activation/inhibition model.","evidence":"Yeast two-hybrid, co-IP, kinase assays at varying SH2B1 concentrations","pmids":["15767667"],"confidence":"Medium","gaps":["In vivo relevance of concentration-dependent inhibition was not tested","No structural model of the dimer interface"]},{"year":2005,"claim":"Global KO revealing severe obesity, leptin resistance, and metabolic syndrome established SH2B1 as an essential endogenous enhancer of leptin sensitivity.","evidence":"SH2B1 null mice with leptin signaling (JAK2, STAT3, IRS2) and metabolic phenotyping","pmids":["16098827"],"confidence":"High","gaps":["Tissue-specific contributions (neuronal vs. peripheral) were not yet dissected"]},{"year":2006,"claim":"Crystal structure of the SH2B1 SH2 domain bound to JAK2 pY813 peptide revealed the structural basis of phosphopeptide specificity and explained preferential JAK2 binding over IR.","evidence":"X-ray crystallography at 2.35 Å resolution with biochemical binding comparisons","pmids":["16824542"],"confidence":"High","gaps":["Full-length SH2B1 structure and mechanism of kinase activation remained unresolved","No structure of SH2B1 bound to IR activation loop"]},{"year":2007,"claim":"Neuron-specific SH2B1 rescue of the KO obesity phenotype demonstrated that the brain is the primary site of SH2B1's metabolic action, redirecting the field from peripheral tissues.","evidence":"Neuron-specific SH2B1β transgenic rescue on KO background; hypothalamic leptin signaling assays; metabolic phenotyping","pmids":["17235396"],"confidence":"High","gaps":["Which neuronal populations are responsible was not defined","Whether peripheral SH2B1 has any independent metabolic role was unclear"]},{"year":2007,"claim":"Defining dual JAK2 binding modes—constitutive non-SH2 binding that restrains basal JAK2 and stimulus-dependent SH2/pY813 binding that activates—refined the model of SH2B1 as a bidirectional kinase regulator.","evidence":"Co-IP with JAK2 Y813F, leptin stimulation, IRS1 phosphorylation assays","pmids":["17565041"],"confidence":"High","gaps":["Structural basis of constitutive inhibitory binding was not determined"]},{"year":2009,"claim":"Demonstrating that SH2B1's SH2 domain alone is sufficient to activate purified IR in vitro, and that SH2B1 protects IRS proteins from dephosphorylation, established two separable peripheral insulin-sensitizing mechanisms.","evidence":"In vitro reconstituted IR kinase assay with purified SH2B1; in vitro IRS dephosphorylation assay; TgKO mice","pmids":["19542202"],"confidence":"High","gaps":["Identity of the phosphatase(s) antagonized was not determined"]},{"year":2010,"claim":"LepR neuron-specific KO revealing abrogated sympathetic nerve activity and BAT thermogenesis established SH2B1 as a critical node in the leptin→SNS→thermogenesis axis.","evidence":"LepR neuron-specific conditional KO, AAV-ablation and overexpression, direct sympathetic nerve recording, BAT thermogenic program assessment","pmids":["32251290"],"confidence":"High","gaps":["Downstream signaling from SH2B1 that specifically activates sympathetic outflow was not identified","Whether SH2B1 is required in other hypothalamic neuron types for thermogenesis was untested"]},{"year":2013,"claim":"Pancreas-specific KO revealing β-cell apoptosis, reduced mass, and impaired PI3K/Akt signaling extended SH2B1's metabolic role to a cell-autonomous β-cell survival and proliferation function.","evidence":"Pancreas-specific conditional KO, HFD metabolic phenotyping, STZ challenge, islet PI3K/Akt assays","pmids":["24150605"],"confidence":"Medium","gaps":["Whether the insulin receptor or IGF-1 receptor is the relevant upstream kinase in β-cells was not resolved","SH2B1 isoform expressed in β-cells was not specified"]},{"year":2013,"claim":"Showing SH2B1β enhances BDNF/TrkB-mediated ERK and Akt signaling for neurite outgrowth broadened its neurotrophic role beyond NGF/TrkA to include BDNF/TrkB pathways.","evidence":"Overexpression of SH2B1β and mutants in PC12-TrkB and hippocampal cells; MEK and PI3K inhibitors; neurite outgrowth assays","pmids":["24260264"],"confidence":"Medium","gaps":["Direct TrkB binding by SH2B1 was not demonstrated biochemically","In vivo relevance for BDNF signaling was not tested"]},{"year":2015,"claim":"Identifying the SH2B1β–IRSp53 interaction as a driver of filopodia and dendritic branching revealed an actin-regulatory pathway linking SH2B1 to neuronal morphogenesis beyond kinase amplification.","evidence":"Reciprocal co-IP, confocal co-localization, overexpression in hippocampal/cortical neurons, neurite/filopodia counting","pmids":["25586189"],"confidence":"Medium","gaps":["Whether this interaction is regulated by neurotrophins was not tested","The relevant upstream signal was not defined"]},{"year":2016,"claim":"Discovery that SH2B1 in a JAK2/IRS2 complex prevents IRS2 ubiquitination linked mTORC1-regulated SH2B1 translation to IRS2 protein stability and β-cell proliferation.","evidence":"4E-BP2 KO mice, co-IP of ternary complex, IRS2 ubiquitination assay, Akt/p27 signaling","pmids":["27217487"],"confidence":"Medium","gaps":["The E3 ubiquitin ligase targeting IRS2 was not identified","Whether SH2B1 directly blocks ubiquitination or acts indirectly was unclear"]},{"year":2016,"claim":"Demonstrating SH2B1 interaction with histone H1 and regulation of chromatin marks (H3K4me3, H3K9me3) at specific promoters during myogenesis revealed an unexpected nuclear/chromatin-regulatory function.","evidence":"ChIP for histone marks and MyoD occupancy, co-IP with histone H1, knockdown myotube assays","pmids":["28039048"],"confidence":"Medium","gaps":["Mechanism by which a cytoplasmic adaptor accesses and modifies chromatin was not elucidated","In vivo muscle phenotype of SH2B1 deletion was not reported"]},{"year":2018,"claim":"Brain-specific KO causing decreased brain weight and pathological aggression, reversed by brain-specific SH2B1 restoration, established SH2B1 as a regulator of brain development and aggression circuits.","evidence":"Global and brain-specific conditional KO, resident-intruder aggression, c-fos mapping in amygdala/PAG, AAV rescue","pmids":["29180441"],"confidence":"Medium","gaps":["The neurotrophin receptor or signaling pathway mediating brain growth effects was not specified","Whether aggression is secondary to brain size reduction was not disentangled"]},{"year":2019,"claim":"Knockin mice with human obesity-associated PH domain variants (P322S, ΔPR) developing obesity and prenatal lethality established the PH domain as functionally critical and validated human genetic associations mechanistically.","evidence":"PH domain variant knockin mice, metabolic phenotyping, glucose/insulin tolerance testing","pmids":["31439647"],"confidence":"Medium","gaps":["The molecular mechanism by which PH domain variants impair SH2B1 function (membrane targeting, IRS binding) was not resolved"]},{"year":2022,"claim":"Identification of SH2B1's role in Schwann cell myelination via cytohesin-2 phosphorylation and Arf6 activation revealed a peripheral nervous system function mechanistically distinct from its kinase-amplifier role.","evidence":"Schwann cell-specific knockdown in vivo, cytohesin-2 Y381F knockin mice, Arf6 activity assays, myelin thickness measurements","pmids":["35077201"],"confidence":"Medium","gaps":["Whether SH2B1 directly phosphorylates cytohesin-2 or acts via an intermediary kinase was not established","Upstream signal triggering this pathway was not identified"]},{"year":2022,"claim":"Showing SH2B1δ localizes to nucleoli via unique basic regions and that this localization is required for maximal neurite complexity and BDNF-induced gene expression established isoform-specific subcellular compartmentalization as a functional determinant.","evidence":"Isoform-specific overexpression in KO hippocampal neurons, confocal microscopy, nucleolar targeting mutagenesis, BDNF gene expression assays","pmids":["35019135"],"confidence":"Medium","gaps":["The nucleolar function (ribosome biogenesis, rRNA processing?) of SH2B1δ was not identified","Whether nucleolar SH2B1δ interacts with specific nucleolar proteins was not tested"]},{"year":2023,"claim":"Cell-type-specific KO in hippocampal inhibitory neurons causing cognitive impairment reversed by ERK inhibition revealed SH2B1 restrains ERK signaling in interneurons to support fluid intelligence.","evidence":"Inhibitory vs. excitatory neuron-specific conditional KO, behavioral testing, single-cell transcriptomics, pharmacological ERK rescue","pmids":["38434247"],"confidence":"Medium","gaps":["The receptor(s) upstream of SH2B1 in inhibitory neurons were not identified","How SH2B1 restrains rather than amplifies ERK in this context (opposite to its canonical role) was not mechanistically explained"]},{"year":null,"claim":"Major unresolved questions include: the full-length structure of SH2B1 and how it simultaneously engages receptors, JAK2, and IRS proteins; the mechanism by which nucleolar SH2B1δ regulates gene expression; and how SH2B1 switches between kinase-activating and kinase-restraining modes in different cell types.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No full-length structural model exists","Context-dependent switch between positive and negative regulation is unexplained","Nucleolar function of SH2B1δ is mechanistically undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[1,4,6,34]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,3,11,15,23]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[1,13]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[10,27,33]},{"term_id":"GO:0005730","term_label":"nucleolus","supporting_discovery_ids":[33]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[13,30]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,2,3,5,6,17,21]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[8,27,28,39]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[33,37]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,5,24]}],"complexes":["JAK2/SH2B1/IRS1-2 ternary complex"],"partners":["JAK2","IRS1","IRS2","NTRK1","INSR","IRSP53","HSPA8","APS"],"other_free_text":[]},"mechanistic_narrative":"SH2B1 is a multivalent cytoplasmic adaptor protein that amplifies receptor tyrosine kinase and JAK-STAT signaling across metabolic, neurotrophic, and developmental contexts. It binds JAK2 constitutively via non-SH2 regions and upon ligand stimulation via its SH2 domain at JAK2 pTyr813, stabilizing an active JAK2 conformation and promoting downstream STAT3/5 and IRS1/2 phosphorylation; it also directly enhances insulin receptor autophosphorylation, assembles JAK2/SH2B1/IRS1-2 ternary complexes that protect IRS proteins from dephosphorylation and ubiquitination, and thereby amplifies PI3K/Akt signaling in multiple tissues including hypothalamus, pancreatic β-cells, liver, muscle, and adipose tissue [PMID:16098827, PMID:15316008, PMID:15314154, PMID:17565041, PMID:19542202, PMID:27217487]. Neuronal SH2B1 is the primary mediator of leptin sensitivity and energy homeostasis—controlling a leptin receptor neuron–sympathetic nervous system–brown adipose tissue thermogenic axis—and additionally regulates brain size, aggression circuitry, and cognitive function by modulating NGF/TrkA- and BDNF/TrkB-dependent ERK, Akt, and actin-reorganization pathways, with isoform-specific subcellular targeting (cytoplasm/plasma membrane for β; nucleolus for δ) determining functional output [PMID:17235396, PMID:32251290, PMID:29180441, PMID:35019135, PMID:38434247]. In the peripheral nervous system, SH2B1 promotes Schwann cell myelination by maintaining cytohesin-2 phosphorylation and Arf6 activity [PMID:35077201]."},"prefetch_data":{"uniprot":{"accession":"Q9NRF2","full_name":"SH2B adapter protein 1","aliases":["Pro-rich, PH and SH2 domain-containing signaling mediator","PSM","SH2 domain-containing protein 1B"],"length_aa":756,"mass_kda":79.4,"function":"Adapter protein for several members of the tyrosine kinase receptor family. Involved in multiple signaling pathways mediated by Janus kinase (JAK) and receptor tyrosine kinases, including the receptors of insulin (INS), insulin-like growth factor 1 (IGF1), nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), glial cell line-derived neurotrophic factor (GDNF), platelet-derived growth factor (PDGF) and fibroblast growth factors (FGFs). In growth hormone (GH) signaling, autophosphorylated ('Tyr-813') JAK2 recruits SH2B1, which in turn is phosphorylated by JAK2 on tyrosine residues. These phosphotyrosines form potential binding sites for other signaling proteins. GH also promotes serine/threonine phosphorylation of SH2B1 and these phosphorylated residues may serve to recruit other proteins to the GHR-JAK2-SH2B1 complexes, such as RAC1. In leptin (LEP) signaling, binds to and potentiates the activation of JAK2 by globally enhancing downstream pathways. In response to leptin, binds simultaneously to both, JAK2 and IRS1 or IRS2, thus mediating formation of a complex of JAK2, SH2B1 and IRS1 or IRS2. Mediates tyrosine phosphorylation of IRS1 and IRS2, resulting in activation of the PI 3-kinase pathway. Acts as a positive regulator of NGF-mediated activation of the Akt/Forkhead pathway; prolongs NGF-induced phosphorylation of AKT1 on 'Ser-473' and AKT1 enzymatic activity. Enhances the kinase activity of the cytokine receptor-associated tyrosine kinase JAK2 and of other receptor tyrosine kinases, such as FGFR3 and NTRK1. For JAK2, the mechanism seems to involve dimerization of both, SH2B1 and JAK2. Enhances RET phosphorylation and kinase activity. Isoforms seem to be differentially involved in IGF1 and PDGF-induced mitogenesis (By similarity)","subcellular_location":"Cytoplasm; Membrane; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9NRF2/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SH2B1","classification":"Not Classified","n_dependent_lines":3,"n_total_lines":1208,"dependency_fraction":0.0024834437086092716},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CALM1","stoichiometry":0.2},{"gene":"CALM2","stoichiometry":0.2},{"gene":"CALM3","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/SH2B1","total_profiled":1310},"omim":[{"mim_id":"615835","title":"CHROMOSOME 16 INVERSION, 0.45-MB","url":"https://www.omim.org/entry/615835"},{"mim_id":"613444","title":"CHROMOSOME 16p11.2 DELETION SYNDROME, 220-KB","url":"https://www.omim.org/entry/613444"},{"mim_id":"608937","title":"SH2B ADAPTOR PROTEIN 1; SH2B1","url":"https://www.omim.org/entry/608937"},{"mim_id":"606641","title":"BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 1; BMIQ1","url":"https://www.omim.org/entry/606641"},{"mim_id":"601665","title":"OBESITY","url":"https://www.omim.org/entry/601665"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Centriolar satellite","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/SH2B1"},"hgnc":{"alias_symbol":["FLJ30542","SH2B"],"prev_symbol":[]},"alphafold":{"accession":"Q9NRF2","domains":[{"cath_id":"2.30.29.30","chopping":"249-254_286-375","consensus_level":"medium","plddt":87.5948,"start":249,"end":375},{"cath_id":"3.30.505.10","chopping":"523-623","consensus_level":"high","plddt":88.1534,"start":523,"end":623},{"cath_id":"1.10.287","chopping":"29-78","consensus_level":"high","plddt":92.4128,"start":29,"end":78}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NRF2","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NRF2-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NRF2-F1-predicted_aligned_error_v6.png","plddt_mean":57.28},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SH2B1","jax_strain_url":"https://www.jax.org/strain/search?query=SH2B1"},"sequence":{"accession":"Q9NRF2","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9NRF2.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9NRF2/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NRF2"}},"corpus_meta":[{"pmid":"16098827","id":"PMC_16098827","title":"Identification of SH2-B as a key regulator of leptin sensitivity, energy balance, and body weight in mice.","date":"2005","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/16098827","citation_count":186,"is_preprint":false},{"pmid":"17235396","id":"PMC_17235396","title":"Neuronal SH2B1 is essential for controlling energy and glucose homeostasis.","date":"2007","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/17235396","citation_count":163,"is_preprint":false},{"pmid":"20808231","id":"PMC_20808231","title":"Recurrent 200-kb deletions of 16p11.2 that include the SH2B1 gene are associated with developmental delay and obesity.","date":"2010","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20808231","citation_count":150,"is_preprint":false},{"pmid":"15316008","id":"PMC_15316008","title":"SH2-B promotes insulin receptor substrate 1 (IRS1)- and IRS2-mediated activation of the phosphatidylinositol 3-kinase pathway in response to leptin.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15316008","citation_count":149,"is_preprint":false},{"pmid":"23160192","id":"PMC_23160192","title":"Human SH2B1 mutations are associated with maladaptive behaviors and obesity.","date":"2012","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/23160192","citation_count":139,"is_preprint":false},{"pmid":"15314154","id":"PMC_15314154","title":"Disruption of the SH2-B gene causes age-dependent insulin resistance and glucose intolerance.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15314154","citation_count":105,"is_preprint":false},{"pmid":"15121872","id":"PMC_15121872","title":"Tyrosine 813 is a site of JAK2 autophosphorylation critical for activation of JAK2 by SH2-B beta.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15121872","citation_count":95,"is_preprint":false},{"pmid":"17140804","id":"PMC_17140804","title":"SH2B1 (SH2-B) and JAK2: a multifunctional adaptor protein and kinase made for each other.","date":"2006","source":"Trends in endocrinology and metabolism: TEM","url":"https://pubmed.ncbi.nlm.nih.gov/17140804","citation_count":94,"is_preprint":false},{"pmid":"17565041","id":"PMC_17565041","title":"SH2B1 enhances leptin signaling by both Janus kinase 2 Tyr813 phosphorylation-dependent and -independent mechanisms.","date":"2007","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/17565041","citation_count":89,"is_preprint":false},{"pmid":"30370521","id":"PMC_30370521","title":"Hsa_circ_0136666 promotes the proliferation and invasion of colorectal cancer through miR-136/SH2B1 axis.","date":"2018","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/30370521","citation_count":84,"is_preprint":false},{"pmid":"10187854","id":"PMC_10187854","title":"SH2-B is required for nerve growth factor-induced neuronal differentiation.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10187854","citation_count":78,"is_preprint":false},{"pmid":"27164951","id":"PMC_27164951","title":"MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.","date":"2016","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/27164951","citation_count":77,"is_preprint":false},{"pmid":"25126397","id":"PMC_25126397","title":"SH2B1 regulation of energy balance, body weight, and glucose metabolism.","date":"2014","source":"World journal of diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/25126397","citation_count":73,"is_preprint":false},{"pmid":"19542202","id":"PMC_19542202","title":"SH2B1 enhances insulin sensitivity by both stimulating the insulin receptor and inhibiting tyrosine dephosphorylation of insulin receptor substrate proteins.","date":"2009","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/19542202","citation_count":72,"is_preprint":false},{"pmid":"20333234","id":"PMC_20333234","title":"Regulation of lifespan, metabolism, and stress responses by the Drosophila SH2B protein, Lnk.","date":"2010","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20333234","citation_count":70,"is_preprint":false},{"pmid":"11238898","id":"PMC_11238898","title":"SH2-B and APS are multimeric adapters that augment TrkA signaling.","date":"2001","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11238898","citation_count":70,"is_preprint":false},{"pmid":"10594240","id":"PMC_10594240","title":"Alternative splicing, gene localization, and binding of SH2-B to the insulin receptor kinase domain.","date":"1999","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/10594240","citation_count":69,"is_preprint":false},{"pmid":"19680438","id":"PMC_19680438","title":"The Drosophila SH2B family adaptor Lnk acts in parallel to chico in the insulin signaling pathway.","date":"2009","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19680438","citation_count":67,"is_preprint":false},{"pmid":"23190452","id":"PMC_23190452","title":"Regulation of insulin and type 1 insulin-like growth factor signaling and action by the Grb10/14 and SH2B1/B2 adaptor proteins.","date":"2013","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/23190452","citation_count":63,"is_preprint":false},{"pmid":"11827956","id":"PMC_11827956","title":"Interaction of fibroblast growth factor receptor 3 and the adapter protein SH2-B. A role in STAT5 activation.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11827956","citation_count":59,"is_preprint":false},{"pmid":"32251290","id":"PMC_32251290","title":"Leptin receptor-expressing neuron Sh2b1 supports sympathetic nervous system and protects against obesity and metabolic disease.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/32251290","citation_count":57,"is_preprint":false},{"pmid":"11940664","id":"PMC_11940664","title":"SH2-B is required for both male and female reproduction.","date":"2002","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11940664","citation_count":52,"is_preprint":false},{"pmid":"15767667","id":"PMC_15767667","title":"Kinase activation through dimerization by human SH2-B.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15767667","citation_count":52,"is_preprint":false},{"pmid":"12521378","id":"PMC_12521378","title":"Adapter protein with a pleckstrin homology (PH) and an Src homology 2 (SH2) domain (APS) and SH2-B enhance insulin-receptor autophosphorylation, extracellular-signal-regulated kinase and phosphoinositide 3-kinase-dependent signalling.","date":"2003","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/12521378","citation_count":50,"is_preprint":false},{"pmid":"10777618","id":"PMC_10777618","title":"SH2-B is required for growth hormone-induced actin reorganization.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10777618","citation_count":48,"is_preprint":false},{"pmid":"11751854","id":"PMC_11751854","title":"SH2-B family members differentially regulate JAK family tyrosine kinases.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11751854","citation_count":47,"is_preprint":false},{"pmid":"21105276","id":"PMC_21105276","title":"Effect of FTO, SH2B1, LEP, and LEPR polymorphisms on weight gain associated with antipsychotic treatment.","date":"2010","source":"Journal of clinical psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/21105276","citation_count":44,"is_preprint":false},{"pmid":"16455776","id":"PMC_16455776","title":"Differential role of SH2-B and APS in regulating energy and glucose homeostasis.","date":"2006","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/16455776","citation_count":42,"is_preprint":false},{"pmid":"10473609","id":"PMC_10473609","title":"SH2-B, a membrane-associated adapter, is phosphorylated on multiple serines/threonines in response to nerve growth factor by kinases within the MEK/ERK cascade.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10473609","citation_count":41,"is_preprint":false},{"pmid":"17228025","id":"PMC_17228025","title":"The SH2B gene is associated with serum leptin and body fat in normal female twins.","date":"2007","source":"Obesity (Silver Spring, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/17228025","citation_count":39,"is_preprint":false},{"pmid":"24971614","id":"PMC_24971614","title":"Functional characterization of obesity-associated variants involving the α and β isoforms of human SH2B1.","date":"2014","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/24971614","citation_count":37,"is_preprint":false},{"pmid":"20484460","id":"PMC_20484460","title":"Critical role of the Src homology 2 (SH2) domain of neuronal SH2B1 in the regulation of body weight and glucose homeostasis in mice.","date":"2010","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/20484460","citation_count":37,"is_preprint":false},{"pmid":"17204555","id":"PMC_17204555","title":"Identification of SH2B2beta as an inhibitor for SH2B1- and SH2B2alpha-promoted Janus kinase-2 activation and insulin signaling.","date":"2007","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/17204555","citation_count":36,"is_preprint":false},{"pmid":"16914724","id":"PMC_16914724","title":"Binding of SH2-B family members within a potential negative regulatory region maintains JAK2 in an active state.","date":"2006","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16914724","citation_count":36,"is_preprint":false},{"pmid":"24260264","id":"PMC_24260264","title":"New function of the adaptor protein SH2B1 in brain-derived neurotrophic factor-induced neurite outgrowth.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24260264","citation_count":35,"is_preprint":false},{"pmid":"31984680","id":"PMC_31984680","title":"BBOX1-AS1 contributes to colorectal cancer progression by sponging hsa-miR-361-3p and targeting SH2B1.","date":"2022","source":"FEBS open bio","url":"https://pubmed.ncbi.nlm.nih.gov/31984680","citation_count":34,"is_preprint":false},{"pmid":"11498022","id":"PMC_11498022","title":"Functional effects of APS and SH2-B on insulin receptor signalling.","date":"2001","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/11498022","citation_count":33,"is_preprint":false},{"pmid":"23270367","id":"PMC_23270367","title":"Mutation screen in the GWAS derived obesity gene SH2B1 including functional analyses of detected variants.","date":"2012","source":"BMC medical genomics","url":"https://pubmed.ncbi.nlm.nih.gov/23270367","citation_count":31,"is_preprint":false},{"pmid":"11036942","id":"PMC_11036942","title":"SH2-B and SIRP: JAK2 binding proteins that modulate the actions of growth hormone.","date":"2000","source":"Recent progress in hormone research","url":"https://pubmed.ncbi.nlm.nih.gov/11036942","citation_count":29,"is_preprint":false},{"pmid":"15082760","id":"PMC_15082760","title":"Adapter protein SH2-B beta undergoes nucleocytoplasmic shuttling: implications for nerve growth factor induction of neuronal differentiation.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15082760","citation_count":29,"is_preprint":false},{"pmid":"24150605","id":"PMC_24150605","title":"SH2B1 in β-cells regulates glucose metabolism by promoting β-cell survival and islet expansion.","date":"2013","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/24150605","citation_count":28,"is_preprint":false},{"pmid":"14565960","id":"PMC_14565960","title":"SH2-B is a positive regulator of nerve growth factor-mediated activation of the Akt/Forkhead pathway in PC12 cells.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14565960","citation_count":28,"is_preprint":false},{"pmid":"16824542","id":"PMC_16824542","title":"Structural basis for phosphotyrosine recognition by the Src homology-2 domains of the adapter proteins SH2-B and APS.","date":"2006","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16824542","citation_count":28,"is_preprint":false},{"pmid":"17312274","id":"PMC_17312274","title":"Adaptor protein SH2-B linking receptor-tyrosine kinase and Akt promotes adipocyte differentiation by regulating peroxisome proliferator-activated receptor gamma messenger ribonucleic acid levels.","date":"2007","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/17312274","citation_count":28,"is_preprint":false},{"pmid":"26077624","id":"PMC_26077624","title":"SH2B1 is critical for the regulation of cardiac remodelling in response to pressure overload.","date":"2015","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/26077624","citation_count":25,"is_preprint":false},{"pmid":"24358267","id":"PMC_24358267","title":"Hepatic SH2B1 and SH2B2 regulate liver lipid metabolism and VLDL secretion in mice.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24358267","citation_count":24,"is_preprint":false},{"pmid":"14766215","id":"PMC_14766215","title":"Roles of a conserved family of adaptor proteins, Lnk, SH2-B, and APS, for mast cell development, growth, and functions: APS-deficiency causes augmented degranulation and reduced actin assembly.","date":"2004","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/14766215","citation_count":24,"is_preprint":false},{"pmid":"35390677","id":"PMC_35390677","title":"Neuronal SH2B1 attenuates apoptosis in an MPTP mouse model of Parkinson's disease via promoting PLIN4 degradation.","date":"2022","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/35390677","citation_count":22,"is_preprint":false},{"pmid":"24948161","id":"PMC_24948161","title":"Common variants in BDNF, FAIM2, FTO, MC4R, NEGR1, and SH2B1 show association with obesity-related variables in Spanish Roma population.","date":"2014","source":"American journal of human biology : the official journal of the Human Biology Council","url":"https://pubmed.ncbi.nlm.nih.gov/24948161","citation_count":22,"is_preprint":false},{"pmid":"21796141","id":"PMC_21796141","title":"Computed tomography analysis of the association between the SH2B1 rs7498665 single-nucleotide polymorphism and visceral fat area.","date":"2011","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21796141","citation_count":22,"is_preprint":false},{"pmid":"25586189","id":"PMC_25586189","title":"SH2B1 and IRSp53 proteins promote the formation of dendrites and dendritic branches.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25586189","citation_count":21,"is_preprint":false},{"pmid":"31439647","id":"PMC_31439647","title":"Crucial Role of the SH2B1 PH Domain for the Control of Energy Balance.","date":"2019","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/31439647","citation_count":20,"is_preprint":false},{"pmid":"31379474","id":"PMC_31379474","title":"Genome-Wide DNA Methylation Analysis Reveals Epigenetic Pattern of SH2B1 in Chinese Monozygotic Twins Discordant for Autism Spectrum Disorder.","date":"2019","source":"Frontiers in neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31379474","citation_count":20,"is_preprint":false},{"pmid":"23590848","id":"PMC_23590848","title":"The Lnk/SH2B adaptor provides a fail-safe mechanism to establish the Insulin receptor-Chico interaction.","date":"2013","source":"Cell communication and signaling : CCS","url":"https://pubmed.ncbi.nlm.nih.gov/23590848","citation_count":19,"is_preprint":false},{"pmid":"29180441","id":"PMC_29180441","title":"Neural deletion of Sh2b1 results in brain growth retardation and reactive aggression.","date":"2018","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/29180441","citation_count":19,"is_preprint":false},{"pmid":"32222636","id":"PMC_32222636","title":"SH2B1 protects cardiomyocytes from ischemia/reperfusion injury via the activation of the PI3K/AKT pathway.","date":"2020","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/32222636","citation_count":19,"is_preprint":false},{"pmid":"23825611","id":"PMC_23825611","title":"Screening for coding variants in FTO and SH2B1 genes in Chinese patients with obesity.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23825611","citation_count":19,"is_preprint":false},{"pmid":"37586323","id":"PMC_37586323","title":"Chromosomal deletions on 16p11.2 encompassing SH2B1 are associated with accelerated metabolic disease.","date":"2023","source":"Cell reports. Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37586323","citation_count":18,"is_preprint":false},{"pmid":"23054017","id":"PMC_23054017","title":"The joint effect of cigarette smoking and polymorphisms on LRP5, LEPR, near MC4R and SH2B1 genes on metabolic syndrome susceptibility in Taiwan.","date":"2012","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/23054017","citation_count":18,"is_preprint":false},{"pmid":"21907990","id":"PMC_21907990","title":"The SH2B1 obesity locus is associated with myocardial infarction in diabetic patients and with NO synthase activity in endothelial cells.","date":"2011","source":"Atherosclerosis","url":"https://pubmed.ncbi.nlm.nih.gov/21907990","citation_count":18,"is_preprint":false},{"pmid":"25471250","id":"PMC_25471250","title":"SH2B1 CpG-SNP is associated with body weight reduction in obese subjects following a dietary restriction program.","date":"2014","source":"Annals of nutrition & metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/25471250","citation_count":18,"is_preprint":false},{"pmid":"30202243","id":"PMC_30202243","title":"SH2B1 promotes NSCLC cell proliferation through PI3K/Akt/mTOR signaling cascade.","date":"2018","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/30202243","citation_count":17,"is_preprint":false},{"pmid":"22669948","id":"PMC_22669948","title":"The SH2B1 adaptor protein associates with a proximal region of the erythropoietin receptor.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22669948","citation_count":16,"is_preprint":false},{"pmid":"30803986","id":"PMC_30803986","title":"Distal chromosome 16p11.2 duplications containing SH2B1 in patients with scoliosis.","date":"2019","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30803986","citation_count":15,"is_preprint":false},{"pmid":"29380446","id":"PMC_29380446","title":"SH2B1 promotes epithelial-mesenchymal transition through the IRS1/β-catenin signaling axis in lung adenocarcinoma.","date":"2018","source":"Molecular carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/29380446","citation_count":15,"is_preprint":false},{"pmid":"22248999","id":"PMC_22248999","title":"Replication of the SH2B1 rs7498665 association with obesity in a Belgian study population.","date":"2011","source":"Obesity facts","url":"https://pubmed.ncbi.nlm.nih.gov/22248999","citation_count":14,"is_preprint":false},{"pmid":"24645678","id":"PMC_24645678","title":"SH2B1 in β-cells promotes insulin expression and glucose metabolism in mice.","date":"2014","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/24645678","citation_count":13,"is_preprint":false},{"pmid":"30015896","id":"PMC_30015896","title":"SH2B1 protects against OGD/R‑induced apoptosis in PC12 cells via activation of the JAK2/STAT3 signaling pathway.","date":"2018","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/30015896","citation_count":13,"is_preprint":false},{"pmid":"32365683","id":"PMC_32365683","title":"Association of the SH2B1 rs7359397 Gene Polymorphism with Steatosis Severity in Subjects with Obesity and Non-Alcoholic Fatty Liver Disease.","date":"2020","source":"Nutrients","url":"https://pubmed.ncbi.nlm.nih.gov/32365683","citation_count":13,"is_preprint":false},{"pmid":"29631267","id":"PMC_29631267","title":"The Effect of SH2B1 Variants on Expression of Leptin- and Insulin-Induced Pathways in Murine Hypothalamus.","date":"2018","source":"Obesity facts","url":"https://pubmed.ncbi.nlm.nih.gov/29631267","citation_count":12,"is_preprint":false},{"pmid":"27217487","id":"PMC_27217487","title":"4E-BP2/SH2B1/IRS2 Are Part of a Novel Feedback Loop That Controls β-Cell Mass.","date":"2016","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/27217487","citation_count":12,"is_preprint":false},{"pmid":"19144050","id":"PMC_19144050","title":"SH2-B beta expression in alveolar macrophages in BAL fluid of asthmatic guinea pigs and its role in NGF-TrkA-mediated asthma.","date":"2009","source":"Respirology (Carlton, Vic.)","url":"https://pubmed.ncbi.nlm.nih.gov/19144050","citation_count":12,"is_preprint":false},{"pmid":"24736401","id":"PMC_24736401","title":"Signaling adaptor protein SH2B1 enhances neurite outgrowth and accelerates the maturation of human induced neurons.","date":"2014","source":"Stem cells translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24736401","citation_count":11,"is_preprint":false},{"pmid":"33356989","id":"PMC_33356989","title":"Hsa_circ_0075960 Serves as a Sponge for miR-361-3p/SH2B1 in Endometrial Carcinoma.","date":"2020","source":"Technology in cancer research & treatment","url":"https://pubmed.ncbi.nlm.nih.gov/33356989","citation_count":11,"is_preprint":false},{"pmid":"18247337","id":"PMC_18247337","title":"PSM/SH2B1 splice variants: critical role in src catalytic activation and the resulting STAT3s-mediated mitogenic response.","date":"2008","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18247337","citation_count":11,"is_preprint":false},{"pmid":"31739166","id":"PMC_31739166","title":"New perspective on SH2B1: An accelerator of cancer progression.","date":"2019","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/31739166","citation_count":10,"is_preprint":false},{"pmid":"26031769","id":"PMC_26031769","title":"Genetic and structural variation in the SH2B1 gene in the Belgian population.","date":"2015","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/26031769","citation_count":10,"is_preprint":false},{"pmid":"28544142","id":"PMC_28544142","title":"Discordant phenotypes in monozygotic twins with 16p11.2 microdeletions including the SH2B1 gene.","date":"2017","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/28544142","citation_count":10,"is_preprint":false},{"pmid":"27802221","id":"PMC_27802221","title":"SH2B1 is Involved in the Accumulation of Amyloid-β42 in Alzheimer's Disease.","date":"2017","source":"Journal of Alzheimer's disease : JAD","url":"https://pubmed.ncbi.nlm.nih.gov/27802221","citation_count":10,"is_preprint":false},{"pmid":"34689140","id":"PMC_34689140","title":"Genetic Obesity in Children: Overview of Possible Diagnoses with a Focus on SH2B1 Deletion.","date":"2021","source":"Hormone research in paediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/34689140","citation_count":9,"is_preprint":false},{"pmid":"23519644","id":"PMC_23519644","title":"Analyses of non-synonymous obesity risk alleles in SH2B1 (rs7498665) and APOB48R (rs180743) in obese children and adolescents undergoing a 1-year lifestyle intervention.","date":"2013","source":"Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association","url":"https://pubmed.ncbi.nlm.nih.gov/23519644","citation_count":9,"is_preprint":false},{"pmid":"29229648","id":"PMC_29229648","title":"Phosphorylation of the Unique C-Terminal Tail of the Alpha Isoform of the Scaffold Protein SH2B1 Controls the Ability of SH2B1α To Enhance Nerve Growth Factor Function.","date":"2018","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/29229648","citation_count":9,"is_preprint":false},{"pmid":"35077201","id":"PMC_35077201","title":"The adaptor SH2B1 and the phosphatase PTP4A1 regulate the phosphorylation of cytohesin-2 in myelinating Schwann cells in mice.","date":"2022","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/35077201","citation_count":8,"is_preprint":false},{"pmid":"35019135","id":"PMC_35019135","title":"The nucleolar δ isoform of adapter protein SH2B1 enhances morphological complexity and function of cultured neurons.","date":"2022","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/35019135","citation_count":7,"is_preprint":false},{"pmid":"21479408","id":"PMC_21479408","title":"Association of genetic variants of MAOA and SH2B1 with bone mineral density in community-dwelling Japanese women.","date":"2008","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/21479408","citation_count":7,"is_preprint":false},{"pmid":"33474638","id":"PMC_33474638","title":"Differential response to a 6-month energy-restricted treatment depending on SH2B1 rs7359397 variant in NAFLD subjects: Fatty Liver in Obesity (FLiO) Study.","date":"2021","source":"European journal of nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/33474638","citation_count":7,"is_preprint":false},{"pmid":"23456070","id":"PMC_23456070","title":"[Expression of SH2B1 adaptor protein in oesophageal cancer and its clinical significance].","date":"2013","source":"Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/23456070","citation_count":7,"is_preprint":false},{"pmid":"14632312","id":"PMC_14632312","title":"Association of SH2-B to phosphorylated tyrosine residues in the activation loop of TrkB.","date":"2002","source":"Research communications in molecular pathology and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/14632312","citation_count":7,"is_preprint":false},{"pmid":"38434247","id":"PMC_38434247","title":"SH2B1 Tunes Hippocampal ERK Signaling to Influence Fluid Intelligence in Humans and Mice.","date":"2023","source":"Research (Washington, D.C.)","url":"https://pubmed.ncbi.nlm.nih.gov/38434247","citation_count":6,"is_preprint":false},{"pmid":"25473371","id":"PMC_25473371","title":"Implication of SH2B1 gene polymorphism studies in gestational diabetes mellitus in Saudi pregnant women.","date":"2014","source":"Saudi journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/25473371","citation_count":6,"is_preprint":false},{"pmid":"36436143","id":"PMC_36436143","title":"SH2B1 variants as potential causes of non-syndromic monogenic obesity in a Brazilian cohort.","date":"2022","source":"Eating and weight disorders : EWD","url":"https://pubmed.ncbi.nlm.nih.gov/36436143","citation_count":6,"is_preprint":false},{"pmid":"25175559","id":"PMC_25175559","title":"SH2B1 increases the numbers of IRSp53-induced filopodia.","date":"2014","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/25175559","citation_count":6,"is_preprint":false},{"pmid":"24103803","id":"PMC_24103803","title":"The SH2B1 obesity locus and abnormal glucose homeostasis: lack of evidence for association from a meta-analysis in individuals of European ancestry.","date":"2013","source":"Nutrition, metabolism, and cardiovascular diseases : NMCD","url":"https://pubmed.ncbi.nlm.nih.gov/24103803","citation_count":5,"is_preprint":false},{"pmid":"29127727","id":"PMC_29127727","title":"Diversity in peptide recognition by the SH2 domain of SH2B1.","date":"2017","source":"Proteins","url":"https://pubmed.ncbi.nlm.nih.gov/29127727","citation_count":5,"is_preprint":false},{"pmid":"33214137","id":"PMC_33214137","title":"Deletion of the Brain-Specific α and δ Isoforms of Adapter Protein SH2B1 Protects Mice From Obesity.","date":"2020","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/33214137","citation_count":5,"is_preprint":false},{"pmid":"29849792","id":"PMC_29849792","title":"Circulating SH2B1 is associated with an increased risk of gastric cancer.","date":"2018","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/29849792","citation_count":5,"is_preprint":false},{"pmid":"26479731","id":"PMC_26479731","title":"SH2B1 orchestrates signaling events to filopodium formation during neurite outgrowth.","date":"2015","source":"Communicative & integrative biology","url":"https://pubmed.ncbi.nlm.nih.gov/26479731","citation_count":5,"is_preprint":false},{"pmid":"28039048","id":"PMC_28039048","title":"SH2B1 modulates chromatin state and MyoD occupancy to enhance expressions of myogenic genes.","date":"2016","source":"Biochimica et biophysica acta. Gene regulatory mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/28039048","citation_count":4,"is_preprint":false},{"pmid":"27530450","id":"PMC_27530450","title":"Evidence for Association between SH2B1 Gene Variants and Glycated Hemoglobin in Nondiabetic European American Young Adults: The Add Health Study.","date":"2016","source":"Annals of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27530450","citation_count":4,"is_preprint":false},{"pmid":"39898036","id":"PMC_39898036","title":"SH2B1 promotes apoptosis in diabetic cataract via p38 MAPK pathway.","date":"2025","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/39898036","citation_count":3,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":52457,"output_tokens":10669,"usd":0.158703},"stage2":{"model":"claude-opus-4-6","input_tokens":14757,"output_tokens":5319,"usd":0.31014},"total_usd":0.468843,"stage1_batch_id":"msgbatch_011rkcQdVV1RaFq9XhcG6df6","stage2_batch_id":"msgbatch_01RzgrJafdF4EWHhj5mNi6dh","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2005,\n      \"finding\": \"SH2B1 (SH2-B) is an endogenous enhancer of leptin sensitivity that binds JAK2 and promotes leptin-stimulated activation of hypothalamic JAK2, phosphorylation of STAT3 and IRS2; SH2B1 null mice show severely impaired leptin signaling and develop obesity, hyperglycemia, and metabolic syndrome.\",\n      \"method\": \"Genetic knockout mouse model; leptin signaling assays (JAK2 activation, STAT3/IRS2 phosphorylation); cultured cell overexpression with PTP1B inhibition assay\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cellular and metabolic phenotypes, replicated across multiple signaling readouts, foundational paper with 186 citations\",\n      \"pmids\": [\"16098827\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"SH2B1 promotes activation of the PI3-kinase pathway in response to leptin by directly binding IRS1 and IRS2 (via its PH and SH2 domains) and mediating formation of a JAK2/SH2B1/IRS1 or IRS2 ternary complex, thereby enhancing leptin-stimulated tyrosine phosphorylation of IRS1/IRS2 and subsequent PI3K/Akt activation.\",\n      \"method\": \"In vitro binding assays (GST pulldown), co-immunoprecipitation in HEK293 cells stably expressing LRb, mutagenesis of SH2B1 binding domains, MEF KO reconstitution\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro pulldown plus co-IP in intact cells plus mutagenesis plus KO rescue, multiple orthogonal methods\",\n      \"pmids\": [\"15316008\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"SH2B1 (SH2-B) directly enhances insulin receptor autophosphorylation and tyrosine phosphorylation of IRS1/IRS2 in an SH2 domain-dependent manner; systemic deletion of SH2-B impairs insulin receptor signaling in liver, muscle, and fat and causes age-dependent hyperinsulinemia, hyperglycemia, and glucose intolerance.\",\n      \"method\": \"Genetic KO mouse; in vitro kinase assays; cultured cell overexpression and KO analysis of IR, IRS1/IRS2 phosphorylation, Akt and ERK1/2 activation\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro kinase assay combined with KO mouse and cell signaling assays, replicated by multiple groups\",\n      \"pmids\": [\"15314154\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Tyrosine 813 is a site of JAK2 autophosphorylation (identified by 2D phosphopeptide mapping and phospho-specific antibody) that is required for SH2B1β to bind JAK2 and to enhance JAK2 activity and STAT5B phosphorylation; the homologous Tyr785 in JAK3 is similarly autophosphorylated and required for SH2B1β binding.\",\n      \"method\": \"2D phosphopeptide mapping, phosphospecific antibody, mutagenesis (Y813F), co-immunoprecipitation, kinase activity assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — phosphopeptide mapping plus phospho-specific antibody plus mutagenesis in intact cells; single rigorous paper\",\n      \"pmids\": [\"15121872\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"SH2B1 regulates leptin/JAK2 signaling by dual mechanisms: (1) constitutive binding via non-SH2 domain to non-phosphorylated JAK2 inhibits basal JAK2; (2) leptin-stimulated JAK2 phosphorylation at Tyr813 recruits the SH2 domain of SH2B1 to activate JAK2; additionally, SH2B1 interacts with IRS1 to facilitate IRS1 phosphorylation independent of JAK2 Tyr813.\",\n      \"method\": \"Co-immunoprecipitation, JAK2 Y813F mutagenesis, leptin stimulation assays, IRS1 phosphorylation assays in cultured cells\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple co-IP experiments with mutagenesis defining two distinct binding modes; single lab but multiple orthogonal approaches\",\n      \"pmids\": [\"17565041\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Neuronal SH2B1β specifically expressed in neural tissue is sufficient to correct metabolic disorders (obesity, leptin resistance, insulin resistance, glucose intolerance) in SH2B1 knockout mice and improves hypothalamic JAK2-mediated leptin signaling, demonstrating that neuronal SH2B1 is the primary site of metabolic action.\",\n      \"method\": \"Neuron-specific SH2B1 transgenic rescue crossed onto KO background (TgKO mice); hypothalamic leptin signaling assays; metabolic phenotyping\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — tissue-specific genetic rescue with defined molecular and phenotypic readouts; 163 citations\",\n      \"pmids\": [\"17235396\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Peripheral SH2B1 directly stimulates insulin receptor catalytic activity (demonstrated by in vitro kinase assay with purified SH2B1) and inhibits tyrosine dephosphorylation of IRS-1/IRS-2 by binding to them; the SH2 domain alone is both required and sufficient for insulin receptor activation.\",\n      \"method\": \"In vitro insulin receptor kinase assay with purified SH2B1; in vitro IRS dephosphorylation assay; TgKO mice expressing SH2B1 only in brain; co-immunoprecipitation\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstituted kinase assay plus in vitro dephosphorylation assay plus domain mutagenesis plus genetic mouse model\",\n      \"pmids\": [\"19542202\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"SH2B1 (SH2-B) and APS exist as homopentamers and/or heteropentamers mediated by their N-terminal dimerization domain; SH2-B multimerization is required for enhancing TrkA autophosphorylation magnitude and duration in response to NGF and for TrkA/SH2-B-mediated morphological differentiation of PC12 cells.\",\n      \"method\": \"Biochemical structure-function analysis; co-immunoprecipitation; dominant-negative overexpression; PC12 cell NGF differentiation assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — structure-function plus cellular assays in single lab; 70 citations\",\n      \"pmids\": [\"11238898\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"SH2B1β (SH2-Bbeta) is required for NGF-induced neuronal differentiation: it binds to activated TrkA via its SH2 domain, is tyrosyl-phosphorylated in response to NGF, and overexpression of a dominant-negative SH2 domain mutant (R555E) blocks NGF-induced neurite outgrowth in PC12 cells without altering TrkA, Shc, PLCγ phosphorylation or ERK1/2 activation, indicating a novel downstream pathway.\",\n      \"method\": \"GST-fusion pulldown, co-immunoprecipitation, overexpression of wild-type and SH2 domain mutant in PC12 cells, neurite outgrowth assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vitro binding plus co-IP plus dominant-negative mutagenesis with clear cellular phenotype; 78 citations\",\n      \"pmids\": [\"10187854\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"SH2B1 (SH2-Bgamma isoform) interacts specifically with the insulin receptor kinase domain, requiring phosphorylation of Y1146 in the activation loop triple-tyrosine motif, making it one of only two signaling molecules shown to interact directly with this residue.\",\n      \"method\": \"In vitro binding assays with insulin receptor kinase domain, mutagenesis of IR Y1146\",\n      \"journal\": \"Mammalian genome\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro binding with mutagenesis; single lab\",\n      \"pmids\": [\"10594240\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"SH2B1β (SH2-Bbeta) is required for growth hormone-induced actin reorganization (membrane ruffling and pinocytosis); it co-localizes with filamentous actin in GH-induced membrane ruffles; both SH2 domain-defective and truncation mutants lacking the N-terminus inhibit GH-induced ruffling, acting via a mechanism distinct from JAK2 kinase stimulation.\",\n      \"method\": \"Cell fractionation, confocal microscopy, overexpression of wild-type and mutant SH2B1 in 3T3-F442A cells, membrane ruffling and pinocytosis assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — localization plus functional assays with mutagenesis; distinct mechanism established\",\n      \"pmids\": [\"10777618\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"SH2B1β specifically activates JAK2 (but not JAK1 or JAK3) when overexpressed, while APS negatively regulates JAK2 and JAK1 but not JAK3; both bind and are phosphorylated by JAK kinases, demonstrating isoform- and kinase-specificity of SH2B family regulation.\",\n      \"method\": \"Overexpression in cells, co-immunoprecipitation, kinase activity/phosphorylation assays for JAK1, JAK2, JAK3, STAT5B\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal binding and kinase activity assays across multiple JAK family members; single lab\",\n      \"pmids\": [\"11751854\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"SH2B1β binds to FGFR3 via the SH2 domain at FGFR3 phosphotyrosines Tyr-724 and Tyr-760; SH2B1β is tyrosyl-phosphorylated by activated FGFR3 mutants and enhances FGFR3-stimulated STAT5 phosphorylation and nuclear translocation.\",\n      \"method\": \"Yeast two-hybrid screen, co-immunoprecipitation, FGFR3 mutagenesis (Y724, Y760), STAT5 nuclear translocation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — yeast two-hybrid confirmed by co-IP plus mutagenesis plus functional STAT5 assay\",\n      \"pmids\": [\"11827956\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"SH2B1β undergoes constitutive nucleocytoplasmic shuttling; a nuclear export sequence (amino acids 224–233) containing two critical lysines is required for cytoplasmic/membrane localization and for SH2B1β to enhance NGF-induced neurite outgrowth; nuclear-export-defective mutants cannot support differentiation despite normal ERK activation.\",\n      \"method\": \"Leptomycin B treatment, NES deletion/mutation, confocal microscopy in PC12 and COS-7 cells, stable overexpression neurite outgrowth assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — localization directly tied to functional consequence via NES mutagenesis; single lab\",\n      \"pmids\": [\"15082760\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"NGF stimulates phosphorylation of SH2B1 (SH2-B) on multiple serines/threonines via kinases downstream of MEK (ERKs 1 and 2 phosphorylate SH2Bbeta on Ser-96 in vitro); however, the S96A mutant still supports NGF-induced neurite outgrowth, suggesting additional MEK-downstream sites are involved.\",\n      \"method\": \"In vitro ERK kinase assay, MEK inhibitor PD98059, protein phosphatase 2A treatment, mutagenesis (S96A), NGF-induced differentiation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro kinase assay plus pharmacological inhibitor plus mutagenesis; single lab\",\n      \"pmids\": [\"10473609\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"SH2B1 homodimerizes (and forms heterodimers with APS) via a unique N-terminal domain; dimerization brings two SH2 domains to bind two JAK2 pTyr813 sites, creating heterotetrameric JAK2-(SH2B1)2-JAK2 complexes that transactivate JAK2 at low adapter concentrations, but inhibit kinase activity at high concentrations.\",\n      \"method\": \"Yeast two-hybrid, cellular transfection co-immunoprecipitation, kinase activity assays at varying SH2B1/APS concentrations\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — yeast two-hybrid confirmed by co-IP plus concentration-dependent kinase assays; mechanistic model supported\",\n      \"pmids\": [\"15767667\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"SH2B1 (and APS) bind JAK2 at multiple sites; binding at pTyr813 is essential for SH2B1-mediated JAK2 activation; a phosphoTyr813-independent binding site mediates inhibition; the region 809–811 in JAK2, likely within JH1/JH2 domains, is a critical component of the regulatory region that SH2B1 binding stabilizes into an active conformation.\",\n      \"method\": \"JAK2 truncation and point mutagenesis, in vitro kinase assays, binding assays for multiple JAK2 sites\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — systematic mutagenesis across JAK2 combined with binding and kinase assays; single lab\",\n      \"pmids\": [\"16914724\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Crystal structure (2.35 Å) of the SH2B1 SH2 domain in complex with the JAK2 pTyr813 phosphopeptide reveals canonical SH2-phosphopeptide binding with specific recognition of glutamate at +1 and hydrophobic at +3 positions; the SH2B1 SH2 domain prefers JAK2 over insulin receptor due to its monomeric state (versus dimeric APS SH2).\",\n      \"method\": \"X-ray crystallography (2.35 Å), biochemical binding assays comparing SH2B1 vs APS SH2 domains\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution crystal structure with biochemical validation of specificity determinants\",\n      \"pmids\": [\"16824542\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"SH2B1β is a positive regulator of NGF-mediated Akt/PKB activation in PC12 cells; it enhances and prolongs NGF-induced phosphorylation of Akt on Ser473, leading to increased phosphorylation of GSK-3 and FOXO forkhead transcription factors and their cytoplasmic retention; a dominant-negative SH2 domain mutant blocks these effects.\",\n      \"method\": \"Stable overexpression of SH2Bbeta and R555E mutant in PC12 cells, Akt kinase assays, phospho-Akt/GSK-3/FOXO western blotting, immunolocalization of FKHR\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — kinase assay plus immunolocalization plus mutagenesis; single lab, multiple endpoints\",\n      \"pmids\": [\"14565960\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"SH2B2β, a novel isoform of SH2B2 lacking an SH2 domain, acts as an endogenous inhibitor of SH2B1: it binds SH2B1 via the dimerization/PH domain and markedly attenuates SH2B1-promoted JAK2 activation, IRS-1 phosphorylation by JAK2, and insulin-stimulated IRS-1 phosphorylation.\",\n      \"method\": \"GST-fusion pulldown in vitro, co-immunoprecipitation in intact cells, JAK2 kinase assays, insulin signaling assays\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro pulldown confirmed by co-IP, combined with functional kinase and signaling assays\",\n      \"pmids\": [\"17204555\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"SH2B1 (SH2-B) promotes adipocyte differentiation by enhancing insulin/IGF-I receptor signaling through Akt, leading to phosphorylation and nuclear exclusion of Foxo1, thereby increasing PPARγ mRNA levels; PPARγ up-regulation by SH2B1 is blocked by PI3K inhibitors but not MEK inhibitors.\",\n      \"method\": \"Retroviral overexpression and KO MEF differentiation assays, PPARγ mRNA quantification, Akt/Foxo1 phosphorylation assays, PI3K and MEK inhibitor treatments\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO and overexpression with pharmacological pathway dissection; single lab\",\n      \"pmids\": [\"17312274\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Neuronal SH2B1 regulates energy balance by controlling a leptin receptor neuron/sympathetic nervous system (SNS)/brown adipose tissue/thermogenesis axis; LepR neuron-specific deletion of Sh2b1 abrogates leptin-stimulated sympathetic nerve activation and impairs BAT thermogenic programs, causing cold intolerance and progressive degeneration of adipose SNS.\",\n      \"method\": \"LepR neuron-specific conditional KO, adult-onset hypothalamic-specific AAV-ablation, hypothalamic overexpression; sympathetic nerve recording; BAT thermogenesis measurement; metabolic phenotyping\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-type-specific KO plus overexpression rescue with defined physiological readouts including direct nerve recording\",\n      \"pmids\": [\"32251290\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The SH2 domain of neuronal SH2B1 is required for maintaining normal body weight and glucose metabolism in vivo; SH2 domain-defective mutant (R555E) expressed neuron-specifically in WT mice promotes obesity and insulin resistance in a dominant-negative manner, while the SH2 domain alone (DeltaN503) is insufficient to rescue the KO phenotype, demonstrating N-terminal regions are also required.\",\n      \"method\": \"Three lines of neuron-specific transgenic mice (WT, R555E, DeltaN503) crossed with SH2B1 KO; metabolic phenotyping; glucose/insulin tolerance tests\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo mutagenesis rescue experiment with three distinct constructs; single lab\",\n      \"pmids\": [\"20484460\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"SH2B1 associates with the erythropoietin receptor (EPO-R) via its SH2 domain at phosphotyrosines 343 and 401 (pYXXL sequence); SH2B1β preferentially associates with EPO-R over JAK2 in hematopoietic cells; constitutive SH2B1 association with EPO-R is necessary for optimal SH2-dependent recruitment; absence of SH2B1 leads to enhanced EPO-R downstream signaling, indicating SH2B1 is a negative regulator of EPO signaling.\",\n      \"method\": \"COLT screening, co-immunoprecipitation, in vitro mixing assays, SH2 domain mutagenesis, EPO stimulation signaling assays in cells lacking SH2B1\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — COLT binding assay plus reciprocal co-IP plus in vitro mixing plus loss-of-function signaling; single lab\",\n      \"pmids\": [\"22669948\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"SH2B1 in pancreatic β-cells promotes β-cell survival and proliferation by enhancing insulin- and IGF-1-stimulated PI3K/Akt activation; pancreas-specific KO mice show increased β-cell apoptosis, decreased proliferation, reduced β-cell mass, and exacerbated glucose intolerance on high-fat diet.\",\n      \"method\": \"Pancreas-specific conditional KO mice; high-fat diet metabolic phenotyping; STZ challenge; β-cell mass histomorphometry; PI3K/Akt signaling assays in INS-1 cells and islets\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — tissue-specific KO with defined molecular (PI3K/Akt) and cellular phenotype readouts; single lab\",\n      \"pmids\": [\"24150605\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"SH2B1 promotes insulin expression in β-cells by enhancing JAK2 activation of the insulin promoter and increasing Pdx1 expression and Pdx1 recruitment to the insulin promoter; SH2B1 knockdown reduces, and overexpression increases, insulin expression and glucose-stimulated insulin secretion.\",\n      \"method\": \"siRNA knockdown and overexpression in INS-1 832/13 cells; insulin promoter-luciferase assay; chromatin immunoprecipitation (ChIP) for Pdx1; SH2B1-deficient islet analysis\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP assay plus promoter reporter plus KD/OE with multiple molecular readouts; single lab\",\n      \"pmids\": [\"24645678\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"SH2B1 mediates pathological cardiac hypertrophy by activating the JAK2/STAT3 signaling cascade; cardiac-specific SH2B1 overexpression exacerbates pressure overload-induced hypertrophy, whereas SH2B1 deletion is protective; pharmacological JAK2 inactivation rescues hypertrophic abnormalities in SH2B1-overexpressing transgenic mice.\",\n      \"method\": \"Cardiac-specific SH2B1 transgenic mice and global KO rat model; aortic banding model; echocardiography; JAK2/STAT3 pathway assays; JAK2 inhibitor rescue experiments\",\n      \"journal\": \"Cardiovascular research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — gain-of-function and loss-of-function mouse/rat models with pharmacological pathway rescue; single lab\",\n      \"pmids\": [\"26077624\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"SH2B1β interacts with IRSp53 via its N-terminal proline-rich domains; SH2B1-IRSp53 complexes co-localize at the plasma membrane and together promote filopodium formation, neurite initiation, and dendritic branching in hippocampal and cortical neurons.\",\n      \"method\": \"Co-immunoprecipitation in vivo and in vitro, confocal co-localization, Triton X-100 fractionation, overexpression of SH2B1β and IRSp53 in neurons, neurite/filopodia counting\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP plus co-localization plus functional neuronal morphology assays; single lab\",\n      \"pmids\": [\"25586189\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"SH2B1 promotes BDNF-induced neurite outgrowth by enhancing MEK-ERK1/2 and PI3K-AKT signaling pathways downstream of TrkB; SH2B1β also enhances BDNF-stimulated STAT3 phosphorylation on Ser727; the SH2 domain and tyrosine phosphorylation of SH2B1β are required for these effects.\",\n      \"method\": \"Overexpression of SH2B1β and mutants in PC12-TrkB and hippocampal cells; pathway inhibitors (MEK, PI3K); neurite outgrowth assays; western blotting of p-ERK, p-AKT, p-STAT3\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological pathway dissection plus mutagenesis plus cellular morphology assays; single lab\",\n      \"pmids\": [\"24260264\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"SH2B1β is phosphorylated by TrkA at Tyr753 in the unique α-tail (and at Tyr439 and Tyr55 shared by α and β isoforms); phosphorylation of Tyr753 in SH2B1α inhibits nucleocytoplasmic cycling and prevents SH2B1α from enhancing NGF-mediated neurite outgrowth, TrkA autophosphorylation, Akt/PLCγ phosphorylation, and gene expression; Y753F mutation restores these functions.\",\n      \"method\": \"Mutagenesis (Y753F and others), co-expression with TrkA, neurite outgrowth assays, western blotting for p-Akt and p-PLCγ, nuclear cycling assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis-based identification of phosphosite with multiple downstream functional readouts; single lab\",\n      \"pmids\": [\"29229648\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"SH2B1 interacts with histone H1 and is required for removal of histone H1 from active transcription sites; SH2B1 promotes histone H3K4me3 induction and H3K9me3 reduction at IGF2 and MYOG promoters/enhancers, is required for MyoD occupancy at these loci, and promotes myogenesis; knockdown delays chromatin condensation and decreases myotube formation.\",\n      \"method\": \"ChIP for histone marks and MyoD occupancy, co-immunoprecipitation with histone H1, SH2B1 knockdown, myotube formation assays\",\n      \"journal\": \"Biochimica et biophysica acta. Gene regulatory mechanisms\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP with multiple histone marks plus co-IP plus loss-of-function phenotype; single lab\",\n      \"pmids\": [\"28039048\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"SH2B1 promotes myelination in peripheral nervous system Schwann cells by maintaining phosphorylation of cytohesin-2 at Tyr381, which is required for Arf6 activity and normal myelin thickness; Schwann cell-specific loss of SH2B1 reduces cytohesin-2 phosphorylation and myelin thickness; SH2B1 and the phosphatase PTP4A1 act antagonistically to control this phosphorylation.\",\n      \"method\": \"Schwann cell-specific knockdown in mice (in vivo), HEK293T co-expression experiments, Y381F cytohesin-2 knockin mice, Arf6 activity assays, myelin thickness measurements\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo Schwann cell-specific KD plus knockin mouse plus biochemical Arf6 activity assays; single lab\",\n      \"pmids\": [\"35077201\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"SH2B1 neuronal protection against MPTP-induced dopaminergic neurodegeneration is mediated by binding to HSC70, which promotes HSC70-dependent recognition and lysosomal translocation/degradation of PLIN4, thereby suppressing lipid peroxidation stress; Sh2b1 deficiency exacerbates PD-like pathology and AAV-HSC70 rescue is effective only in WT but not Sh2b1-deficient mice.\",\n      \"method\": \"MPTP mouse PD model, Sh2b1 KO and neuron-specific overexpression, co-IP of SH2B1-HSC70, PLIN4 degradation assays, AAV-HSC70 rescue, lipid peroxidation measurement\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — co-IP defining complex plus in vivo rescue epistasis; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"35390677\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"The brain-specific SH2B1δ isoform localizes primarily to nucleoli (driven by two unique highly basic regions) and to the plasma membrane; its nucleolar localization is required for SH2B1δ to maximally enhance neurite complexity and BDNF-induced expression of Egr1, Arc, and FosL1 in hippocampal neurons.\",\n      \"method\": \"Isoform-specific overexpression in Sh2b1 KO hippocampal neurons, confocal microscopy, mutagenesis of nucleolar targeting regions, neurite morphology analysis, BDNF-induced gene expression assays\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — localization tied to functional consequence via domain mutagenesis; single lab\",\n      \"pmids\": [\"35019135\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"4E-BP2 deletion induces translation of SH2B1, which then forms a complex with IRS2 and JAK2 that prevents IRS2 ubiquitination; this SH2B1-dependent stabilization of IRS2 increases Akt signaling, reduces p27, and promotes β-cell proliferation and survival, linking mTORC1 signaling to IRS2 stability through SH2B1.\",\n      \"method\": \"4E-BP2 KO mice, co-immunoprecipitation (SH2B1/IRS2/JAK2 complex), IRS2 ubiquitination assay, Akt/p27 signaling assays, cytokine treatment survival assays\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — co-IP defining ternary complex plus ubiquitination assay plus KO mouse; single lab\",\n      \"pmids\": [\"27217487\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"The PH domain of SH2B1 is critical for energy balance and glucose homeostasis; mice homozygous for a human obesity-associated P322S PH domain variant show substantial prenatal lethality; mice with a two-amino acid deletion in the PH domain (ΔPR) develop obesity and insulin resistance beyond that attributable to adiposity alone.\",\n      \"method\": \"PH domain variant knockin mouse models (P322S and ΔPR); metabolic phenotyping; glucose and insulin tolerance testing\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo PH domain mutagenesis in mice with defined metabolic phenotyping; single lab\",\n      \"pmids\": [\"31439647\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"The SH2 domain of SH2B1 binds diverse phosphotyrosine-containing peptides (JAK2 pY813, insulin receptor activation loop, IRS-1/2) with distinct thermodynamic signatures; residues K575 and R578 play distinct roles in different binding modes; crystal structure reveals conformationally plastic loops enabling recognition of chemically disparate +3 position residues.\",\n      \"method\": \"Binding assays (ITC/fluorescence), X-ray crystallography of SH2B1 SH2 domain, alanine scanning mutagenesis of binding residues\",\n      \"journal\": \"Proteins\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — structural plus biochemical binding with mutagenesis; single lab\",\n      \"pmids\": [\"29127727\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Hippocampal SH2B1 in inhibitory (but not excitatory) neurons controls fluid intelligence-related cognitive functions (working memory, short-term recognition memory, behavioral flexibility) by restraining ERK signaling; selective ablation of Sh2b1 in hippocampal inhibitory neurons causes aberrantly enhanced ERK signaling, and pharmacological ERK inhibition reverses associated behavioral impairments.\",\n      \"method\": \"Cell-type-specific conditional KO in mouse hippocampus (inhibitory vs excitatory neurons), behavioral cognitive testing, single-cell transcriptomic profiling, pharmacological ERK inhibitor rescue\",\n      \"journal\": \"Research (Washington, D.C.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — cell-type-specific KO with pathway-specific pharmacological rescue; single lab\",\n      \"pmids\": [\"38434247\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"PSM/SH2B1 splice variants (with activity order γ > δ > α > β) enhance Src kinase catalytic activity by increasing V(max) and decreasing K(m) for ATP; SH2B1 variants and Src are found in the same immune complex; SH2B1 also enhances Src-mediated STAT3 activation; dominant-negative PH or SH2 domain peptides inhibit Src activity.\",\n      \"method\": \"Co-immunoprecipitation, in vitro Src kinase assays (V(max)/K(m) measurement), Src inhibitor herbimycin A, dominant-negative peptide mimetics, STAT3 reporter assays\",\n      \"journal\": \"Journal of cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro kinase assay with Km/Vmax parameters plus co-IP plus dominant-negative; single lab\",\n      \"pmids\": [\"18247337\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Neural deletion of Sh2b1 decreases brain weight and increases reactive aggression; brain-specific KO mice show increased c-fos immunoreactivity in amygdala and periaqueductal gray (core aggression circuits); brain-specific restoration of Sh2b1 normalizes brain size and reverses pathological aggression; at the molecular level, Sh2b1 enhances neurotrophin-stimulated neuronal differentiation and protects against oxidative stress-induced neuronal death.\",\n      \"method\": \"Global and brain-specific conditional KO; resident-intruder aggression paradigm; c-fos immunoreactivity mapping; brain-specific AAV restoration; neurotrophin signaling and oxidative stress protection assays\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — brain-specific KO and rescue with defined circuit-level and molecular readouts; single lab\",\n      \"pmids\": [\"29180441\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"SH2B1 protects cardiomyocytes from ischemia/reperfusion injury via activation of the PI3K/AKT pathway; adenovirus-mediated SH2B1 overexpression reduces I/R-induced apoptosis, ROS, and inflammation; pharmacological PI3K/AKT inhibition (LY294002) abolishes SH2B1's protective effects.\",\n      \"method\": \"In vivo I/R model (LAD ligation) and in vitro H/R model in cardiomyocytes; adenoviral SH2B1 overexpression; PI3K inhibitor LY294002; apoptosis, ROS, and inflammation assays\",\n      \"journal\": \"International immunopharmacology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — gain-of-function with pharmacological rescue but no KO or binding confirmation; single lab\",\n      \"pmids\": [\"32222636\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SH2B1 is a cytoplasmic adaptor protein that acts as a positive regulator of multiple receptor tyrosine kinase and JAK-associated cytokine receptor signaling pathways: it binds constitutively (via non-SH2 regions) and upon leptin/GH stimulation (via its SH2 domain to JAK2 pTyr813) to JAK2, enhancing JAK2 catalytic activity and stabilizing an active conformation; it also directly stimulates insulin receptor autophosphorylation and assembles ternary complexes (JAK2/SH2B1/IRS1 or IRS2) that promote IRS1/2 phosphorylation while protecting IRS proteins from dephosphorylation, thereby amplifying PI3K/Akt signaling; neuronal SH2B1 additionally controls leptin receptor neuron–SNS–BAT thermogenesis, brain development, aggression circuits, and neurotrophic factor (NGF, BDNF) signaling by regulating TrkA/TrkB-mediated ERK, Akt, and actin-reorganization pathways, with isoform-specific functions determined by distinct C-terminal tails and subcellular localizations (cytoplasm/plasma membrane for β; nucleolus for δ).\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"SH2B1 is a multivalent cytoplasmic adaptor protein that amplifies receptor tyrosine kinase and JAK-STAT signaling across metabolic, neurotrophic, and developmental contexts. It binds JAK2 constitutively via non-SH2 regions and upon ligand stimulation via its SH2 domain at JAK2 pTyr813, stabilizing an active JAK2 conformation and promoting downstream STAT3/5 and IRS1/2 phosphorylation; it also directly enhances insulin receptor autophosphorylation, assembles JAK2/SH2B1/IRS1-2 ternary complexes that protect IRS proteins from dephosphorylation and ubiquitination, and thereby amplifies PI3K/Akt signaling in multiple tissues including hypothalamus, pancreatic β-cells, liver, muscle, and adipose tissue [PMID:16098827, PMID:15316008, PMID:15314154, PMID:17565041, PMID:19542202, PMID:27217487]. Neuronal SH2B1 is the primary mediator of leptin sensitivity and energy homeostasis—controlling a leptin receptor neuron–sympathetic nervous system–brown adipose tissue thermogenic axis—and additionally regulates brain size, aggression circuitry, and cognitive function by modulating NGF/TrkA- and BDNF/TrkB-dependent ERK, Akt, and actin-reorganization pathways, with isoform-specific subcellular targeting (cytoplasm/plasma membrane for β; nucleolus for δ) determining functional output [PMID:17235396, PMID:32251290, PMID:29180441, PMID:35019135, PMID:38434247]. In the peripheral nervous system, SH2B1 promotes Schwann cell myelination by maintaining cytohesin-2 phosphorylation and Arf6 activity [PMID:35077201].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Establishing SH2B1 as a TrkA-binding adaptor required for NGF-induced neuronal differentiation answered whether this SH2 protein had neurotrophic signaling functions beyond its known role in cytokine receptor pathways.\",\n      \"evidence\": \"GST pulldown, co-IP, and dominant-negative SH2 mutant (R555E) blocking neurite outgrowth in PC12 cells\",\n      \"pmids\": [\"10187854\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The downstream pathway mediating neurite outgrowth was distinct from ERK and remained unidentified\", \"Whether SH2B1 acts on TrkA autophosphorylation magnitude was not tested\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Demonstrating direct SH2B1γ interaction with the insulin receptor activation loop at pY1146 established SH2B1 as one of the first adaptor proteins binding this specific autophosphorylation site.\",\n      \"evidence\": \"In vitro binding assays with IR kinase domain mutagenesis\",\n      \"pmids\": [\"10594240\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of this binding on IR kinase activity was not measured\", \"Only in vitro binding without cellular validation\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Linking SH2B1β to GH-induced actin reorganization (membrane ruffling) revealed a cytoskeletal effector function distinct from its JAK2 kinase-stimulatory role.\",\n      \"evidence\": \"Confocal co-localization with F-actin, mutagenesis of SH2 and N-terminal domains, ruffling/pinocytosis assays in 3T3-F442A cells\",\n      \"pmids\": [\"10777618\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"The actin-regulatory intermediates (Rho GTPases, WASP) were not identified\", \"In vivo relevance was not tested\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Discovering that SH2B1 forms homopentamers/heteropentamers with APS via its N-terminal domain, and that multimerization is required for TrkA activation, established oligomerization as a core mechanistic feature.\",\n      \"evidence\": \"Biochemical structure-function analysis, co-IP, dominant-negative overexpression, PC12 NGF differentiation\",\n      \"pmids\": [\"11238898\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Stoichiometry later revised to dimers; pentameric model not independently confirmed\", \"Structural basis of multimerization was unresolved\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Identifying JAK2 pTyr813 as the SH2B1 SH2-domain docking site, and showing it is required for SH2B1-mediated JAK2 activation, defined the key phosphoswitch controlling the SH2B1–JAK2 regulatory interaction.\",\n      \"evidence\": \"2D phosphopeptide mapping, phospho-specific antibody, Y813F mutagenesis, co-IP, kinase assays\",\n      \"pmids\": [\"15121872\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How SH2B1 binding at pY813 mechanistically activates the JAK2 kinase domain was not structurally resolved\", \"Role of a second, phosphotyrosine-independent binding site was only later characterized\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Demonstrating that SH2B1 assembles a JAK2/SH2B1/IRS1-2 ternary complex via PH and SH2 domains to amplify leptin-stimulated PI3K/Akt signaling established its scaffold function beyond simple kinase activation.\",\n      \"evidence\": \"GST pulldown, co-IP in LRb-expressing HEK293, mutagenesis, MEF KO reconstitution\",\n      \"pmids\": [\"15316008\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of scaffold vs. kinase-enhancer function was not separated in vivo\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Showing that SH2B1 directly stimulates insulin receptor autophosphorylation and that global KO causes diabetes-like metabolic syndrome established SH2B1 as a bona fide insulin signaling amplifier with physiological consequence.\",\n      \"evidence\": \"In vitro IR kinase assays, KO mouse metabolic phenotyping, IRS1/2 and Akt phosphorylation assays\",\n      \"pmids\": [\"15314154\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the IR-activating and JAK2-activating functions are mechanistically identical was unresolved\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Resolving the oligomeric state to dimers and showing that SH2B1 dimers bridge two JAK2 molecules into a transactivating heterotetramer provided a concentration-dependent activation/inhibition model.\",\n      \"evidence\": \"Yeast two-hybrid, co-IP, kinase assays at varying SH2B1 concentrations\",\n      \"pmids\": [\"15767667\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo relevance of concentration-dependent inhibition was not tested\", \"No structural model of the dimer interface\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Global KO revealing severe obesity, leptin resistance, and metabolic syndrome established SH2B1 as an essential endogenous enhancer of leptin sensitivity.\",\n      \"evidence\": \"SH2B1 null mice with leptin signaling (JAK2, STAT3, IRS2) and metabolic phenotyping\",\n      \"pmids\": [\"16098827\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Tissue-specific contributions (neuronal vs. peripheral) were not yet dissected\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Crystal structure of the SH2B1 SH2 domain bound to JAK2 pY813 peptide revealed the structural basis of phosphopeptide specificity and explained preferential JAK2 binding over IR.\",\n      \"evidence\": \"X-ray crystallography at 2.35 Å resolution with biochemical binding comparisons\",\n      \"pmids\": [\"16824542\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length SH2B1 structure and mechanism of kinase activation remained unresolved\", \"No structure of SH2B1 bound to IR activation loop\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Neuron-specific SH2B1 rescue of the KO obesity phenotype demonstrated that the brain is the primary site of SH2B1's metabolic action, redirecting the field from peripheral tissues.\",\n      \"evidence\": \"Neuron-specific SH2B1β transgenic rescue on KO background; hypothalamic leptin signaling assays; metabolic phenotyping\",\n      \"pmids\": [\"17235396\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which neuronal populations are responsible was not defined\", \"Whether peripheral SH2B1 has any independent metabolic role was unclear\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Defining dual JAK2 binding modes—constitutive non-SH2 binding that restrains basal JAK2 and stimulus-dependent SH2/pY813 binding that activates—refined the model of SH2B1 as a bidirectional kinase regulator.\",\n      \"evidence\": \"Co-IP with JAK2 Y813F, leptin stimulation, IRS1 phosphorylation assays\",\n      \"pmids\": [\"17565041\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of constitutive inhibitory binding was not determined\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Demonstrating that SH2B1's SH2 domain alone is sufficient to activate purified IR in vitro, and that SH2B1 protects IRS proteins from dephosphorylation, established two separable peripheral insulin-sensitizing mechanisms.\",\n      \"evidence\": \"In vitro reconstituted IR kinase assay with purified SH2B1; in vitro IRS dephosphorylation assay; TgKO mice\",\n      \"pmids\": [\"19542202\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the phosphatase(s) antagonized was not determined\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"LepR neuron-specific KO revealing abrogated sympathetic nerve activity and BAT thermogenesis established SH2B1 as a critical node in the leptin→SNS→thermogenesis axis.\",\n      \"evidence\": \"LepR neuron-specific conditional KO, AAV-ablation and overexpression, direct sympathetic nerve recording, BAT thermogenic program assessment\",\n      \"pmids\": [\"32251290\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream signaling from SH2B1 that specifically activates sympathetic outflow was not identified\", \"Whether SH2B1 is required in other hypothalamic neuron types for thermogenesis was untested\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Pancreas-specific KO revealing β-cell apoptosis, reduced mass, and impaired PI3K/Akt signaling extended SH2B1's metabolic role to a cell-autonomous β-cell survival and proliferation function.\",\n      \"evidence\": \"Pancreas-specific conditional KO, HFD metabolic phenotyping, STZ challenge, islet PI3K/Akt assays\",\n      \"pmids\": [\"24150605\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether the insulin receptor or IGF-1 receptor is the relevant upstream kinase in β-cells was not resolved\", \"SH2B1 isoform expressed in β-cells was not specified\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Showing SH2B1β enhances BDNF/TrkB-mediated ERK and Akt signaling for neurite outgrowth broadened its neurotrophic role beyond NGF/TrkA to include BDNF/TrkB pathways.\",\n      \"evidence\": \"Overexpression of SH2B1β and mutants in PC12-TrkB and hippocampal cells; MEK and PI3K inhibitors; neurite outgrowth assays\",\n      \"pmids\": [\"24260264\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct TrkB binding by SH2B1 was not demonstrated biochemically\", \"In vivo relevance for BDNF signaling was not tested\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identifying the SH2B1β–IRSp53 interaction as a driver of filopodia and dendritic branching revealed an actin-regulatory pathway linking SH2B1 to neuronal morphogenesis beyond kinase amplification.\",\n      \"evidence\": \"Reciprocal co-IP, confocal co-localization, overexpression in hippocampal/cortical neurons, neurite/filopodia counting\",\n      \"pmids\": [\"25586189\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether this interaction is regulated by neurotrophins was not tested\", \"The relevant upstream signal was not defined\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Discovery that SH2B1 in a JAK2/IRS2 complex prevents IRS2 ubiquitination linked mTORC1-regulated SH2B1 translation to IRS2 protein stability and β-cell proliferation.\",\n      \"evidence\": \"4E-BP2 KO mice, co-IP of ternary complex, IRS2 ubiquitination assay, Akt/p27 signaling\",\n      \"pmids\": [\"27217487\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"The E3 ubiquitin ligase targeting IRS2 was not identified\", \"Whether SH2B1 directly blocks ubiquitination or acts indirectly was unclear\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Demonstrating SH2B1 interaction with histone H1 and regulation of chromatin marks (H3K4me3, H3K9me3) at specific promoters during myogenesis revealed an unexpected nuclear/chromatin-regulatory function.\",\n      \"evidence\": \"ChIP for histone marks and MyoD occupancy, co-IP with histone H1, knockdown myotube assays\",\n      \"pmids\": [\"28039048\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which a cytoplasmic adaptor accesses and modifies chromatin was not elucidated\", \"In vivo muscle phenotype of SH2B1 deletion was not reported\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Brain-specific KO causing decreased brain weight and pathological aggression, reversed by brain-specific SH2B1 restoration, established SH2B1 as a regulator of brain development and aggression circuits.\",\n      \"evidence\": \"Global and brain-specific conditional KO, resident-intruder aggression, c-fos mapping in amygdala/PAG, AAV rescue\",\n      \"pmids\": [\"29180441\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"The neurotrophin receptor or signaling pathway mediating brain growth effects was not specified\", \"Whether aggression is secondary to brain size reduction was not disentangled\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Knockin mice with human obesity-associated PH domain variants (P322S, ΔPR) developing obesity and prenatal lethality established the PH domain as functionally critical and validated human genetic associations mechanistically.\",\n      \"evidence\": \"PH domain variant knockin mice, metabolic phenotyping, glucose/insulin tolerance testing\",\n      \"pmids\": [\"31439647\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"The molecular mechanism by which PH domain variants impair SH2B1 function (membrane targeting, IRS binding) was not resolved\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identification of SH2B1's role in Schwann cell myelination via cytohesin-2 phosphorylation and Arf6 activation revealed a peripheral nervous system function mechanistically distinct from its kinase-amplifier role.\",\n      \"evidence\": \"Schwann cell-specific knockdown in vivo, cytohesin-2 Y381F knockin mice, Arf6 activity assays, myelin thickness measurements\",\n      \"pmids\": [\"35077201\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether SH2B1 directly phosphorylates cytohesin-2 or acts via an intermediary kinase was not established\", \"Upstream signal triggering this pathway was not identified\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Showing SH2B1δ localizes to nucleoli via unique basic regions and that this localization is required for maximal neurite complexity and BDNF-induced gene expression established isoform-specific subcellular compartmentalization as a functional determinant.\",\n      \"evidence\": \"Isoform-specific overexpression in KO hippocampal neurons, confocal microscopy, nucleolar targeting mutagenesis, BDNF gene expression assays\",\n      \"pmids\": [\"35019135\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"The nucleolar function (ribosome biogenesis, rRNA processing?) of SH2B1δ was not identified\", \"Whether nucleolar SH2B1δ interacts with specific nucleolar proteins was not tested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Cell-type-specific KO in hippocampal inhibitory neurons causing cognitive impairment reversed by ERK inhibition revealed SH2B1 restrains ERK signaling in interneurons to support fluid intelligence.\",\n      \"evidence\": \"Inhibitory vs. excitatory neuron-specific conditional KO, behavioral testing, single-cell transcriptomics, pharmacological ERK rescue\",\n      \"pmids\": [\"38434247\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"The receptor(s) upstream of SH2B1 in inhibitory neurons were not identified\", \"How SH2B1 restrains rather than amplifies ERK in this context (opposite to its canonical role) was not mechanistically explained\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Major unresolved questions include: the full-length structure of SH2B1 and how it simultaneously engages receptors, JAK2, and IRS proteins; the mechanism by which nucleolar SH2B1δ regulates gene expression; and how SH2B1 switches between kinase-activating and kinase-restraining modes in different cell types.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No full-length structural model exists\", \"Context-dependent switch between positive and negative regulation is unexplained\", \"Nucleolar function of SH2B1δ is mechanistically undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [1, 4, 6, 34]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 3, 11, 15, 23]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [1, 13]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [10, 27, 33]},\n      {\"term_id\": \"GO:0005730\", \"supporting_discovery_ids\": [33]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [13, 30]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 2, 3, 5, 6, 17, 21]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [8, 27, 28, 39]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [33, 37]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 5, 24]}\n    ],\n    \"complexes\": [\n      \"JAK2/SH2B1/IRS1-2 ternary complex\"\n    ],\n    \"partners\": [\n      \"JAK2\",\n      \"IRS1\",\n      \"IRS2\",\n      \"NTRK1\",\n      \"INSR\",\n      \"IRSp53\",\n      \"HSPA8\",\n      \"APS\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}